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The nanostructure of the extracellular matrix (ECM) can direct cell attachment, alignment, and 
organization.  Similarly, ECM micropatterns such as tubes and branched networks organize cells 
into larger functional units.  To mimic this complex cellular microenvironment in tissue 
engineered scaffolds, we need new fabrication methods capable of constructing structures on 
both the nano- and micro-scale.  Furthermore, these methods should be compatible with a variety 
of biomaterials to allow tailoring of mechanical and degradation properties.  Electrospinning is a 
useful technique for creating fibrous scaffolds, but there have been few reports introducing 
micropatterns.   
This dissertation describes the development of a new versatile fabrication approach that 
combines electrospinning with a fused deposition modeling (FDM) 3D printer to create 
micropatterns that mimic tissues.  We hypothesized that these structures would improve cell 
migration and positioning within electrospun scaffolds.  We tested this hypothesis by patterning 
scaffolds for peripheral nerves and microvascular networks.  We first demonstrate the feasibility 
of templated electrospinning for generating linear channels in fibrous nerve guides that mimic 
the endoneurial/fascicular tubes of nerve and promote faster Schwann cell infiltration.  This 
micropatterning technique was combined with FDM production of branched templates to create 
microvascular networks within fibrous scaffolds.   Finally, material properties were improved by 
developing a technique to fabricates scaffolds with electrospun poly(glycerol sebacate)(PGS).   
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TISSUE ENGINEERING 
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1.0  INTRODUCTION 
Tissue engineering has made significant progress in developing clinical therapies for flat (skin), 
hollow (bladder), and avascular (cartilage) tissues.1-3  However, successful tissue engineering of 
larger organs has been more elusive for several reasons: 
1) A hierarchical 3D structure must be reconstructed and populated by appropriate cell 
type.4  These structures include linear channels (eg: fascicles in nerve, muscle, and tendon; 
Haversian canals in bone) and branched networks (eg: biliary ducts in the liver, respiratory 
airways of the lungs, and collection ducts in kidneys) 
2) Vascular support is necessary since cells cannot survive on diffusion alone in solid organs 
greater than 2-3mm3 volume.4-6   
3) Porosity must be balanced with mechanical/degradation properties to resist physiological 
loads while permitting resorption and remodeling.7    
Due to the small scale of many biological structures, microfabrication has been useful in 
investigating the role of topographical cues on cell morphology, differentiation, and adhesion.8  
However, most microfabrication (MF) and solid free-form fabrication (SFF) methods were not 
designed with the porosity and degradability necessary for tissue engineering applications.   
Similarly, many tissue engineering approaches cannot match the high resolution and spatial 
control of microfabrication.  Thus, significant hurdles remain for successfully creating 
biomimetic scaffolds for large organ repair. 
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1.1 SIGNIFICANCE 
Organ transplantation remains the standard treatment for failure of vital organs.  However, since 
the number of candidates on waiting lists (Figure 1) far exceeds the allograft donors, thousands 
die before receiving a transplant.9  The kidney wait list is the largest and has increased steadily 
over the past decade to almost 60,000 candidates currently.10  Liver has the second largest 
waiting list and remains close to 15,000.10  Lung and heart waiting lists have shown the most 
rapid increases in the past 5 years.10  While the number of candidates awaiting a particular organ 
fluctuates by year, the overall trend of organ shortage continues to grow.  This trend is expected 
to worsen as the average life span grows.  One promising solution is the use of tissue engineering 
to circumvent the donor shortage and avoid the need of immunosuppressants.11   
 
Figure 1. Patients on Organ Waiting List by Year.  Reproduced from 10 
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1.2 TISSUE ENGINEERING 
The term tissue engineering was coined in the early 1990s as “an interdisciplinary field that 
applies engineering and life sciences toward the development of biological substitutes for the 
repair or regeneration of tissue or organ functions.”12  Tissue engineering approaches combine 
scaffolds, cells, and stimulatory cues to promote healing.  This dissertation focuses on the 
development of new fabrication methods to produce scaffolds that closely resemble the 
structures and physical properties of the tissues they aim to replace. 
Tissue engineering scaffolds 1) define a space for regeneration, 2) serve as a temporary 
substitute for function and 3) provide a substrate for cell adhesion and ingrowth.13  Cells can be 
pre-seeded before implantation or recruited from the host after implantation.11  Scaffolds can also 
act to release or retain bioactive molecules to guide regeneration.  A fundamental challenge of 
scaffold design lies in mimicking the complex cellular microenvironment.11, 14  Facets of this 
microenvironment include porosity, biodegradability, cell-material interactions, and mechanical 
properties.13  Porosity is critical for permitting cell infiltration and nutrient diffusion.1  
Biodegradability is necessary to allow constructive remodeling and should match the rate of 
extracellular matrix (ECM) deposition to maintain structural stability while avoiding extended 
inflammation or encapsulation.15  Mechanical properties of the scaffold can influence a range of 
cellular activities including attachment, migration, gene expression, and differentiation, thus 
influencing the remodeling response.16-18  Some applications, especially bone and muscle, 
require load-bearing functions where the scaffold must provide mechanical forces until the 
remodeled tissue can undertake this function.  As a result, scaffold design must balance between 
mechanical support and degradation rate.19 
 4 
Methods to generate scaffolds with complex architecture have generally taken two 
approaches: decellularization or scaffold fabrication.  Decellularization removes cellular debris 
from autologous or xenogeneic sources while retaining bioactive components of the extracellular 
matrix (collagen, fibronectin, elastin) and growth factors.  Research in this field has produced 
decellularization protocols for many tissues and successfully regenerated flat tissues such as skin 
and bladder.20  However, decellularization of larger organs is more likely to leave residual DNA 
and cellular debris.2  Aggressive protocols can be used, but these chemicals can easily damage 
fragile ECM molecules. 2, 21-25  Recellularization of parenchymal cells into their proper locations 
is also more difficult in larger organs.  Furthermore, disruption of the vascular network during 
decellularization also disrupts the vascular network, exposing collagen which can induce 
thrombogenesis unless endothelialized.5, 26, 27 Other challenges of decellularization include 
retaining growth factor bioactivity during sterilization and achieving reproducibility.1, 25  
Because of these limitations, our work focused on scaffold fabrication approaches. 
1.3 SCAFFOLD FABRICATION 
Fabrication methods can be grouped into three categories: conventional, microfabrication (MF), 
and solid freeform fabrication (SFF) methods.  Conventional processing methods can produce 
porous or fibrous scaffolds with most biomaterials.  While techniques have been developed to 
control microstructure (eg. channels,28 pores,29 fibers30), the random nature of these processes 
make it difficult to controllably create micropatterns.31  In contrast, MF and SFF can spatially 
control formation of long-range (global) micropatterns in 2D and 3D respectively.32  Since the 
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3D environments surrounding cells have been shown to affect their behavior, it is important for 
TE scaffolds to recreate these 3D structures.33 
1.3.1 Conventional Fabrication Methods  
To introduce porosity into scaffolds, local pores have been introduced by solvent casting 
particulate leaching, freeze drying, of gas foaming methods.32, 34, 35  While these techniques have 
been refined to adjust pore size and alignment, the formation of these pores is still largely a 
random process, making it difficult to construct larger structures (eg. channels) with spatial 
precision.13, 32  Additionally, the high porosity of these scaffolds often results in low and 
inhomogeneous mechanical strength.13, 32  
The extracellular matrix is comprised of fibrous proteins and proteoglycans (50-500 nm 
diameter) that serve mechanical as well as bioactive functions.9, 36  Fiber-forming processes such 
as (thermally induced) phase separation, molecular self-assembly, and electrospinning have been 
used to reproduce similar fibrous structures.37  We focus on electrospinning as a versatile method 
for fabricating fibrous constructs in the nano-microfiber range. 
Electrospinning is an old method of fiber production that uses electric charge to draw 
fibers from a polymer solution or melt.38  Electrospinning is performed by pumping a polymer 
solution through a needle (spinneret) with a high applied voltage.  As charge accumulates in the 
solution droplet, electrostatic repulsion overcomes the surface tension allowing formation of a 
Taylor cone, whereby the polymer enters flight toward a grounded or oppositely charged 
collector.  If sufficient intermolecular forces exist to overcome Rayleigh instability, a solid 
stream of polymer will form.  Otherwise, small polymer droplets will be deposited by 
electrospraying.  As the solvent evaporates during flight, nonaxisymmetric whipping of the 
 6 
polymer stream occurs due to Rayleigh instability.38  This causes fiber to narrow to 0.01-10µm 
while drying during flight and then depositing on a collector.39   
Electrospinning is a relatively inexpensive method that permits control of fiber diameter 
and alignment for a variety of natural and synthetic polymers.39, 40  Additionally, electrospinning 
has grown in popularity for tissue engineering research because of the resemblance of 
electrospun fibers to the extracellular matrix.41, 42  A challenge of using electrospinning for tissue 
engineering scaffolds is the limited cellular infiltration into the fibers due to tight fiber packing.9, 
43  Furthermore, modified approaches may be necessary to create 3D constructs from the typical 
2D fiber deposition.44-50 
1.3.2 Microfabrication 
Miniaturization of the integrated circuit and optoelectronics industries introduced early micro- 
and nano-fabrication techniques such as photolithography and etching.51, 52  These tools have 
since been used to develop devices such as microsensors, microactuators, microfluidics, and 
microelectronics, collectively known as microelectromechanical systems (MEMS).  These 
methods are capable of producing extremely high resolution (250nm) but are largely limited to 
materials such as photoresists, silicon, and glass.53   
The development of soft lithography reduced time and cost by eliminating the clean room 
in addition to enabling micropatterning of soft materials.54  One soft lithography method, 
microcontact printing (Figure 2), enables the patterning of biological molecules while replica 
molding (Figure 3A) is useful for introducing topographical features into substrates such as 
grooves, channels, and posts.53, 54  Other soft lithography processes include microtransfer 
molding, micromolding in capillaries, and solvent-assisted micromolding (Figure 3B-D).  Soft 
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lithography traditionally uses poly(dimethylsiloxane) PDMS, a soft, gas permeable, and 
transparent material.  These properties make PDMS substrates useful for supporting cellular 
applications and the development of organ-on-a-chip devices53, 55, 56  Because of the small 
volume, large throughput, and high sensitivity of these devices, soft lithography continues to be 
developed as an efficient diagnostic tool for real-time diagnostics, DNA sequencing, biodefense, 
implantable drug delivery, and minimally-invasive imaging.52, 57-59  Methods to fabricate TE 
scaffolds are being developed by stacking or rolling porous and degradable substrates patterned 
by soft lithography.60-63   
 
Figure 2. Soft Lithography Method of Microcontact Printing. Reproduced from 53 
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Figure 3. Soft Lithography Techniques (a) Replica molding, (b) microtransfer molding, (c) micromolding 
in capillaries, (d) solvent-assisted micromolding.  Reproduced from 53  
1.3.3 Solid Freeform Fabrication 
Solid freeform fabrication (SFF) includes a wide range of automated techniques that use 
computers to manufacture scaffolds in a layer-by-layer fashion.  Advantages of SFF include 
precise control of material deposition as well as the ability to customize geometry for an 
individual patient based on data collected from anatomical scans.13  SFF equipment varies in 
price from a few hundred dollars for hobbyist devices to tens of thousands for industrial 
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equipment.  SFF methods can be categorized by different features such as type of material 
printed (polymer, metal, powder, photopolymer solution, cells, hydrogels) or mode of action 
(light, nozzle, printer).13  We briefly describe these methods using the American Society for 
Testing and Materials (ASTM) terminology.  In addition to directly structures as printed, they 
can also be used as a sacrificial mold with indirect processing.13 
Powder bed fusion, or selective laser sintering (SLS)/ selective laser melting (SLM), uses 
thermal energy to selectively fuse defined regions in a bed of powder.  This method offers 
resolution between 50µm and 500µm as determined by particle size and laser.  This method has 
traditionally been used for processing metals (eg. titanium) but has recently been expanded to 
include hydroxyapatite, poly(caprolactone), poly(lactic acid), poly(hydroxybutyrate-co-
hydroxyvalerate), and bioglass.64-70  Because of the high modulus of most of these materials, 
SLS scaffolds are mostly used for bone and dental implants. 
 
Figure 4. Powder bed fusion.  Reproduced from 71 
 
Vat photopolymerization, or stereolithography (SLA), uses focused light to selectively 
cure a photopolymer with high resolution (1-30µm).  Use of two photon polymerization or 
digital-mirror devices (DMD) can greatly improve resolution or fabrication speed respectively.72-
74  Applications within TE have used photocrosslinkable polymers (eg. poly(propylene fumarate) 
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(PPF), methacrylated PCL) and hydrogels (eg. gelatin-methacrylate, gelatin-methacrylamide, 
hyaluronic acid-methacrylate, and poly(ethylene glycol-diacrylate).72, 73, 75  While these 
hydrogels can incorporate cells during the build process, the photopolymers and initiators may be 
cytotoxic to cells.76-78   
 
Figure 5. Vat polymerization.  Reproduced from 71 
 
Material extrusion, or fused deposition modeling (FDM), mechanically extrudes a 
material through a nozzle and fuses it to the previous layer.  While hobbyist equipment using this 
method is some of the least expensive, this method requires stock material in filament form.  
Commercially-available filament was traditionally limited to acrylonitrile-butadiene-styrene 
(ABS) although poly(lactic acid) (PLA) and poly(vinyl alcohol) (PVA) have recently become 
available.  Although custom-made filament has been used to print poly(caprolactone) (PCL), 
hopper- and syringe-based extruders are gaining popularity for printing a wider range of 
materials.79-82  Furthermore, the low resolution (xy:250µm, z:50µm) of traditional FDM is being 
improved in pressure assisted microsyringe which uses custom fabricated glass capillaries to 
obtain features of approximately 10-30µm.63, 71 
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Figure 6. Material Extrusion.  Reproduced from 71 
 
Material jetting (3D plotting) selectively deposits droplets of soft build materials.  These 
droplets have traditionally been initiated by thermal or actuated inkjet printing (Figure 7 A/B).  
Printing of biological material (termed cytoscribing) dates back to 1988 where a Hewlett-
Packard printer was used deposit collagen and fibronectin.83  Extrusion and laser forward transfer 
(Figure 7 C/D) can also be considered variations of 3D plotting with characteristics of FDM and 
SLA respectively.  The use of aqueous build materials permits printing of proteins and growth 
factors in addition to live cells in hydrogels or cell spheroids.  3D plotting of poly(ethylene 
glycol) diacrylate/alginate and agarose have been used to make heart valves and blood vessels 
respectively.84, 85   
Challenges of these methods involve the effect of shear stresses (10m/s)86 and heat for 
thermal inkjet on cell viability and function.  By optimizing conditions, patterned fibroblasts as 
well as hippocampal and cortical neurons cells, have achieved over 90% viability while 
maintaining electrophysiological activity.86, 87 The heat has also been used to transfect printed 
cells.  Other limitations include a low resolution and clogging.88   
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Figure 7. Material Jetting A) Thermal inkjet printing via microbubbles.  (B) Inkjet printing by mechanical 
actuation. (C) Microextrusion. (D) Laser forward transfer. Reproduced from 31 
Binder jetting or 3D printing combines the powder bed of SLS with the material jetting 
technique to selectively bind powder materials with a liquid bonding agent.  This method is 
typically used with ceramics such as hydroxyapatite for bone scaffolds.89, 90  Scaffolds produced 
by this method suffer from low mechanical strength and a resolution around 300um.90, 91   
 
Figure 8. Binder Jetting.  Reproduced from 71 
 
Sheet lamination, or selective deposition lamination (SDL)/laminated object 
manufacturing (LOM), uses a laser to cut a pattern in each layer of paper, plastic, or metal.  
These layers are adhered to the prior layer by bonding under a heated roller that glues or welds 
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the layers together.71 This method can provide high resolution (xy:10µm, z:100µm) but has not 
seen much use in tissue engineering applications.71 
 
Figure 9. Sheet lamination.  Reproduced from 71 
1.3.4 Combination Approaches 
As technology converges, new methods borrow features of multiple modalities.  For instance, 
electrohydrodynamic jet (also referred to as direct write melt electrospinning or near field 
electrospinning) demonstrates characteristics of both FDM and electrospinning.92-94  
Combination technologies may provide solutions to shortcomings of any one method.  FDM-
printed PCL was combined with 3D plotted hydrogels or electrospun PCL to improve strength 
and porosity respectively.80, 95  Similarly, electrospinning was combined with 3D plotting or 
electrospraying of cells to create hybrid constructs with improved cellular integration.43, 96 
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2.0  SPECIFIC AIMS 
The extracellular matrix is comprised of fibrous proteins and proteoglycans that facilitate cell 
attachment and permit diffusion of nutrients.97 Additionally, large organs contain hierarchical 3D 
micropatterns.97  It is difficult to fabricate TE scaffolds with both fibrous nanostructure and 
global micropatterns using existing techniques.  For example, electrospinning is capable of 
fabricating nanofibrous scaffolds but cannot introduce global structures with defined spatial 
precision.  In contrast, SFF methods is ideal for complex 3D design, but does not typically 
produce features that are fibrous or of the proper scale for cell attachment.80   
The objective of this work was to develop a micropatterning technique (templated 
electrospinning) to introduce global structures with a specified shape and orientation into 
electrospun scaffolds.  This step-wise process enables production of multi-layered structures with 
different materials and alignment.  The fibrous nature of electrospun scaffolds is appropriate for 
mass transfer but is typically too dense to permit substantial cell migration.9, 43  Thus, we 
hypothesized that cell migration into electrospun scaffolds could be facilitated and guided by 
incorporation of micropatterns.  We tested this hypothesis by patterning scaffolds for peripheral 
nerves and microvascular networks.  These structures were selected because of the micro-sized 
features and the increasing complexity from nerve to blood vessels which allowed us to 
sequentially improve our technique.  Additionally, the ubiquitous nature of neurovascular 
structures throughout the body makes this relevant for most tissues.  While others have combined 
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SFF with electrospinning to make composite structures98, 99 or used sacrificial electrospun 
fibers,100-106 to the best of our knowledge this might be the first report of defined sacrificial 
micropatterns in electrospun scaffolds.  
This dissertation addressed the following specific aims: 
1.   Introduce linear patterns into electrospun scaffolds to promote cellular infiltration into 
a biomimetic nerve guide.  Specifically, we: 
 Introduced and maintained microchannel structures in fibrous nerve guides. 
 Incorporated aligned fibers in microchannels to provide topographical guidance cues. 
 Demonstrated Schwann cell infiltration into nerve guide microchannels 
2.  Introduce bifurcating patterns into electrospun scaffolds to mimic branching structures 
of microvascular networks.  Specifically, we: 
 Created custom vascular pattern with nontoxic water-soluble material 
 Used templated electrospinning to transfer pattern into fibrous construct  
 Demonstrated feasibility of endothelializing microvascular scaffolds 
3. Improve degradation, mechanical, and delamination properties by electrospinning 
poly(glycerol sebacate) (PGS).  Specifically, we:  
 Electrospun PGS with minimal alterations 
 Investigated mechanical properties and cytocompatibility of fibrous PGS 
 Used electrospun PGS to create multi-laminate microvascular constructs 
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3.0  TEMPLATED ELECTROSPINNING WITH LINEAR PATTERNS TO 
PRODUCE BIOMIMETIC NERVE GUIDES 
Chapter Aim 
The aim of this chapter was to develop templated electrospinning techniques using linear 
patterns to mimic the architecture of native nerve.  We hypothesized that reproducing the tubular 
structure of endoneurial tubes and fascicles with microchannels would confine axon paths to 
reduce misdirection.  Additionally, aligned fibers have been shown to direct axons similar to the 
longitudinally-aligned Schwann cells of the Bands of Bungner.  Since aligned fibers are difficult 
to present in 3D scaffolds, we maximized surface area of aligned fibers by lining the 
microchannels.  These biomimetic nerve guides demonstrated increased Schwann cell infiltration 
compared to other designs.   
Background 
Peripheral nerve injuries accompany approximately 2.8% of trauma patients, or 100,000 
people  in the US and Europe annually.107, 108  These injuries cause loss of sensation and muscle 
function, in addition to painful neuropathies in patients.109  Due to an innate regenerative 
capacity of peripheral nerves, injuries yielding insignificant or no loss of axon continuity 
typically repair naturally.110, 111  However, severe injuries causing complete nerve transection 
require surgical intervention.  Small gaps are surgically anastamosed without tension while 
larger gaps are bridged by an implant to provide structural, mechanical, and biochemical support. 
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112  Although autografts produce donor site morbidity and yield incomplete or inconsistent 
recovery, they are still preferred over alternative nerve guides and remain the clinical gold 
standard.113  Consequently, prosthetic alternatives capable of matching or exceeding the 
performance of autografts are a highly active area of research.113, 114   
Native nerve is organized into a hierarchical structure of parallel channels that are 
separated by three layers: endoneurium, perineurium, and epineurium (Figure 10).  Axons 
ensheathed within endoneurial tubes extend from the cell body longitudinally toward their distal 
target.  These tubes are bundled together within the perineurium to form fascicles.  The whole 
nerve is enclosed by the epineurium.   
 
Figure 10. Structure of native nerve. Modified from 115 
 
Severed axons of peripheral nerves possess an innate ability to repair via Wallerian 
regeneration (Figure 11).  During this process, Schwann cells (SC) are mobilized to phagocytose 
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cell debris.  Schwann cells also proliferate and longitudinally align, forming the Bands of 
Bungner which can provide topographical cues to regenerating axons.    However, axon 
extension is a slow process and requires proper guidance to re-establish the appropriate 
connections.    Peripheral nerve guides can serve as the temporary scaffolds to support and direct 
axon extension.   
 
Figure 11. Process of Wallerian Regeneration. Reproduced from115 
3.1 INCORPORATION OF PARALLEL CHANNELS WITHIN FIBROUS NERVE 
GUIDES 
3.1.1 Introduction 
Existing nerve guides 
Clinically-available nerve grafts are limited to single-lumen conduits constructed of collagen, 
poly(glycolic acid), poly (D,L-lactide-co-ε-caprolactone), poly(vinyl alcohol), or decellularized 
extracellular matrix (ECM) and yield outcomes inferior to autografts.112  Moderate experimental 
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success has been achieved by nerve autografts and muscle basal lamina.116  We believe this may 
be due in part to the confinement of the nerve within the complex multi-channel structure of the 
basal lamina.  Through numerous fabrication methods researchers have attempted to mimic these 
designs but fail to achieve the same success.117   
To address this challenge, we designed the first multi-channel nerve guide composed entirely 
of electrospun fibers intended to mimic the fascicular architecture and extracellular matrix 
respectively.  Our design satisfies 3 design criteria that have not been achieved by previous 
methods.  1) Our design incorporates a high density of channels which is uncommon in other 
templating approaches.  2) We have greater control of channel size and regularity compared to 
freeze drying methods.  3) Our design consists of interconnected spaces between fibers instead of 
the solid walls created by casting methods.  Additionally, we can customize many aspects of the 
design such as fiber diameter, composition, and alignment, in addition to channel diameter and 
spacing.  We anticipate this design being especially useful for nerve repair in the future by 
incorporating aligned fibers, which can guide axon growth. 
3.1.2 Experimental Section 
Electrospinning 
A 14% polycaprolactone (PCL) (Mn=80,000, Sigma) solution was prepared by dissolving PCL 
pellets in 5:1 trifluoroethanol:water at room temperature under agitation overnight.118  Random 
fibers were deposited on the aluminum face of a custom collector (Figure 13A) during horizontal 
stationary electrospinning (Figure 12A).  The collector also had two fine tooth combs (18 teeth 
per cm) attached to the sides to align sutures in a regularly-spaced parallel pattern.  Radially-
aligned fibers were deposited around the guide via rotating electrospinning (Figure 12B) to 
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prevent unraveling.   For both electrospinning methods, the collector was placed 25 cm from the 
needle and the polymer solution was pumped through a 21 gauge needle at a flow rate of 
25µl·min-1.  Electrostatic potentials of 15 kV positive and 10 kV negative were attached to the 
needle and collector respectively. 
 
Figure 12. Diagram of electrospinning(A) A stationary electrospinning set-up is used to produce a random 
fiber mesh.  A polymer solution is pumped from syringe at a constant rate.  A positive voltage is attached to syringe 
needle; a negative voltage is attached to an aluminum collector plate.  The positively-charged polymer dries to form 
a thin fiber during flight toward the negatively-charged collection plate. (B) Rotational electrospinning set-up is 
used to produce radially-aligned fibers.  Same process as stationary electrospinning is used except the fibers are 
deposited on a mandrel rotating in front of the collector 
 
Nerve Guide Preparation 
A random mesh of PCL fibers were deposited on the aluminum face of a collector by 
stationary electrospinning a set volume, V1 µL, of PCL solution (Figure 13A).  Sutures were 
woven taut around the teeth on the collector to form N parallel strand templates atop the 
electrospun fibers (Figure 13B).  Sutures were covered with a second layer of random PCL fibers 
by electrospinning a set volume, V2 µL (Figure 13C).  The entire construct was placed in a 
vacuum chamber overnight to remove residual solvent. The thickness of each layer is adjusted by 
varying volumes V1 and V2 and the number of channels equals N.  
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After drying, the sutures were cut at both ends to release the electrospun mat from the 
collector (Figure 13D).  The multilayered electrospun mat was rolled up parallel to the sutures 
and secured with two collagen sutures (Figure 13E).  Recent designs used parafilm to secure the 
template strands rather than tying with sutures.  The outside was then sealed with a thin sheath of 
aligned PCL microfibers by electrospinning 50µL PCL while rotating the nerve guide at 60 rpm 
in front of the collector (Figure 12B). This outer sheath helps to prevent nerve guide from 
unraveling.  The patterning sutures were removed, creating aligned channels in their void.  The 
nerve guide preparation was completed by trimming the guide to the desired length by cutting 
each end (Figure 13F).  This removes the peripheral regions of the electrospun mat with low 
fiber density.  Prior to trimming the guide, it was soaked in deionized water (diH2O) for 1 hour 
and frozen on dry ice.  The integrity of the micro-channels was better maintained during 
sectioning if water was allowed to penetrate the nerve guide and frozen to mechanically support 
it during cutting.  The nerve guides were stored in microcentrifuge tubes until use.   
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Figure 13. Fabrication scheme for suture-templated electrospinning nerve guide.Deposit a thin layer (V1) 
of random electrospun PCL fibers via stationary electrospinning setup.  (B) Create channel template by stringing 
aligned sutures across first PCL layer and attaching to combs on sides of the collector.  (C) Deposit second thin layer 
(V2) of random electrospun PCL fibers via stationary setup.  (D) After drying excess solvent in vacuum, cut sutures 
on both ends and trim flat sheet to length.  (E) Roll up nerve guide and secure.  Electrospin aligned PCL sheath 
around outside of guide by rotating electrospinning set-up.  The template strands of one end of the nerve guide are 
placed in a tube and secured by parafilm.  This is rotated at 60rpm in front of collector plate as 50 µl of aligned 
fibers are deposited around the exposed region.  (F) Sutures are manually removed.  Electrospun nerve guide is 
soaked in water to allow penetration and guide is cut after freezing on dry ice. 
 
Porosity  
The porosity of the guide, including channels, was estimated used the geometric 
equations outlined in the paper by Yang.119   Briefly, the porosity, P, is calculated from equation 
1.   
          (1) 
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Vp is the volume of the polymer and Vt is the total volume of the guide, obtained from the 
following equations.   
 (mt-mass of total guide)  (dp-density of polymer) (2) 
  (rt-radius of total guide)  (l=length)   (3) 
The term Vp/Vt in equation 1 represents the volume occupied by the polymer.  Thus, one minus 
this value provides the volume of the free space in the guide including gaps between fibers and 
the channels.  The volume (Vc) and percent porosity (Pc) contributed from the channels is also 
obtained from equations 4 and 5. 
  (rc-radius of a channel) (n=number of channels) (4) 
         (5) 
Scanning electron microscope (SEM) 
SEM samples were prepared by cutting thin (approximately 1-2 mm) transverse slices of 
nerve guides with a scalpel and adhering to an aluminum stub using carbon tape.  The samples 
were dehydrated in a desiccator overnight. The samples were coated with 3nm of gold with a 
Cressington Sputter Coater and grounded to the stub with aluminum paint.  Samples were 
imaged with a Jeol JSM-6330F SEM.   
Analysis of electrospinning parameters 
Reproducibility and layer thickness.  Three guides were produced using V1/V2= 75 µL and 
35 templates of 100 µm diameter.  It should be noted that this was spun on a collector 7cm long 
and 4cm wide, so not all of the deposited fibers were in the portion used for the guide.  The 
qualitative structure of 1-2 mm hydrated sections were observed on an Olympus SZX10 stereo 
microscope and compared to others where the layer thicknesses were varied such that V1/V2=40, 
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V1=40/V2=100, and V1/V2=100.  Additionally, porosities determined from the above equations 
were reported. 
Channel diameter. A guide was fabricated using template diameters of 20, 70, 100 and 
150µm.  The number of templates and layer thicknesses were adjusted based on template size.  
Optical images of 1-2mm hydrated samples were again viewed an Olympus SZX10 stereo 
microscope.  ImageJ was used to determine channel size via two orthogonal diameter 
measurements for 10 channels per transverse-section.  Average channel diameter (+/-) standard 
deviation is reported.   
Cell Culture 
Rat Schwannoma cell line RT4-D6P2T (ATCC CRL-2768) was kindly provided by the 
Badylak lab.  Cells were cultured with Dulbecco’s Modified Eagle Medium (DMEM) (ATCC 
30-2002) with 10% fetal bovine serum (FBS), 1% antibiotic/antimycotic (Cellgro 30-004-Cl) in 
incubators at 37oC and 5% carbon dioxide. 
Nerve guides were sliced to lengths of 1.2 cm, sterilized by ethylene oxide, and washed 
in sterile 1X PBS for 2 days on an orbital shaker, changing PBS after the first day.  Nerve guides 
were then incubated with 10µg/mL laminin solution at 37oC for 13 hours.  Nerve guides were 
washed once in 1X phosphate buffer solution (PBS) prior to cell seeding. 
Cells (passage #8) were trypsinized and resuspended at a concentrated 7,633 cells/µL.  A 
65µL solution of cell suspension was pipetted into each side of the guide for a total of 1x106 
cells per guide.  This not absorbed by the guide was pipette into each end a second time.  Nerve 
guides were placed in 12 well plates and 1mL media was added to each well.  The plates were 
placed in a 37oC incubator for 1 hour.  Nerve guides were then placed on a shaker in the 
incubator for 1 hour before transferring to new 12-well plates to eliminate the large number of 
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cells adhered to culture plate.  Guides were incubated while shaking until evaluation at 4 and 11 
day time points for 4',6-diamidino-2-phenylindole (DAPI) (n=3) and 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) (n=3).  
Schwann cell SEM preparation.  Guides containing cells were placed in a fixation 
solution (2.5% glutaraldehyde in 1X PBS) overnight at 4oC.  Nerve guides were then dehydrated 
through serial dilution in 25, 30, 50, 70, 80, 90, 100 percent ethanol in water.  This was followed 
by dehydration in 3:1, 1:1, and 1:3 (3 times) ethanol:hexamethyldisilazane (HDMS).  Nerve 
guides were immersed for 15 minutes in each solution.  The nerve guide was then left in 100 
percent HDMS in fume hood overnight for complete drying.  The nerve guide was cut at a 45 
degree angle cross-section to reveal the interior of the guide.  Samples were prepared on SEM 
stubs as previously described. 
Live/Dead/DAPI.  Live/dead solution was prepared by adding calcein AM (20µM) and 
ethidium homodimer (1µM) to DMEM without phenol red or FBS.  Three nerve guides from 
each time point were washed three times with 1X PBS before incubating in1.5 mL live/dead 
solution for 3 hours.  Guides were then cut in half, frozen in OCT, and sectioned on a microtome 
to produce transverse and longitudinal slices (8 µm thick).  The cell nuclei were stained with 
DAPI mounting solution and viewed on a Nikon Eclipse Ti inverted microscope.  Analysis 
focused on identifying cell infiltration (location of cells relative to channels) and proliferation 
(number of cells).  Due to background staining associated with the guide fibers, no 
immunofluorescence was used.  Image look-up table (LUT) minimum threshold and G-value 
were adjusted to improve the contrast so DAPI could be seen in relation to the structures in the 
guide. 
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MTT.  Three nerve guides, three guides without cells, and calibration curve cells seeded 
at 1, 0.5, 0.25, and 0.125 million cells per tissue culture polystyrene (TCPS) well and acclimated 
for 3 hours in culture were used for the MTT assay.   Each sample was washed three times with 
1X PBS to remove residual media containing phenol red.  MTT solution (0.5mg/mL media 
without FBS or phenol red) was added to each well for 3 hours at 37oC.  Small sections from the 
ends and center of the guides were section for imaging.  Images did not clearly show MTT 
crystals and are not shown. DMSO was added to the remaining pieces of the seeded nerve guides 
and to the other samples.  Mechanical disruption was applied to the seeded guides to solublize 
MTT trapped in the fibers.  After 30 minutes, the solutions were removed and added to 96 well 
plates in triplicate for absorbance reading at 540nm.    
3.1.3 Results and Discussion 
Multi-channel electrospun design mimics nerve micropattern 
Rationale for multi-channel design. An array of parallel microchannels is present in healthy 
nerves and  preservation of this endoneurial structure is an optimistic indicator in the prognosis 
of nerve injuries 111.  Therefore, the major goal of our design was to incorporate endoneurial-like 
structures in a nerve guide.  Single lumen nerve guides aid regeneration by concentrating 
chemical signals and restricting infiltration of inflammatory cells.112  However, single lumen 
conduits fail to present a multi-channel structure like that of a native nerve.  Furthermore, 
collapse of a single lumen conduit drastically impairs nerve repair.117  
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Figure 14. Optical images of transverse-sections of multi-channel guidesof difficult layer thickness and 35 
templates. (100 µm diameter).  Total porosity (P) and percent channel porosity (Pc) is reported for each guide.  (A-
C) V1/V2=75 µL, (D) V1/V2=40, (E) V1=40/V2=100, (F) V1/V2=100. 
 
Existing multi-channel designs. Multi-channeled nerve guides have been fabricated by a 
variety of methods including freeze drying, injection molding, thermally-induced phase 
separation (TIPS), electrodeposition, and various combinations of these methods.116, 117, 120-129 
There are several key differences distinguishing our design from existing methods of producing 
multi-lumen guides.  Our guide has electrospun fibers with an open porous structures to facilitate 
mass transport.    Contrarily, mold casting, lithographic, and deposition techniques generate 
nerve guides with thick or continuous walls which are likely to limit mass transfer.116, 117, 125, 128, 
130, 131  Additionally, we report a high channel density, while many of these mold casting 
methods produce very few channels.  Our fabrication scheme can create well-defined channels 
with a diameter as small as 33 µm.  This can be contrasted with the other common methods such 
as freeze-drying, TIPS, and gas foaming which are porous but often lack control of channel size, 
orientation, and interconnectivity.120-123  Other approaches capable of producing porous guides 
with defined channels are limited to 150 µm minimum diameter rods used to make the channels 
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and the difficulties associated with aligning and removing rod templates with large aspect ratios. 
119, 126, 129  Finally, our layered fabrication scheme will allow us to make future modifications to 
incorporate aligned fibers within channels to provide nanometer-scale topographical guidance.  
Aligned electrospun fibers have demonstrated utility in directing nerve outgrowth as well as 
inducing morphology changes.30, 132-136  The ability to perform this type of modification has not 
been demonstrated by other methods, making our approach unique.137 
Rationale for electrospinning. Native nerve is surrounded by an extracellular matrix that 
is fibrous and porous.138  The process of electrospinning has gained much attention in tissue 
engineering in recent years for its ability to controllably produce sub-micron to micron-sized 
fibers that mimic the fibrous nature of ECM.42   However, since electrospinning is best-suited for 
production of two-dimensional meshes, incorporation into three-dimensional constructs 
appropriate for nerve regeneration has been difficult and limited.139 
Current electrospinning methods.  Existing methods of incorporating electrospun fibers 
into nerve guides radially- or axially-align fibers on the circumference of a hollow conduit or 
insert flat sheets into the lumen.136, 140, 141   These methods do not utilize the entire cross-sectional 
area for adhesion and guidance or may not be appropriately oriented.  Bundles of longitudinally-
aligned electrospun fibers can also be inserted inside a cylindrical nerve guide to fill the lumen, 
but unlike channels, they do not confine nerve to particular paths.141-144  Additionally, tight 
packing of these bundles may inhibit axon and Schwann cell migration.  In contrast to existing 
electrospun nerve guides, our design creates a complex 3-dimensional construct with open 
channels to guide the nerve and Schwann cells between the fibrous substrate. 
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Fabrication 
Our fabrication process successfully demonstrates proof of concept for a nerve guide 
constructed entirely of electrospun fibers.  The two electrospun layers encapsulated the templates 
and exhibited sufficient interaction to prevent delamination.  We believe that the insulating 
properties and smooth surface of the templates allow easy removal from the electrospun fibers 
without disrupting the channel architecture despite a large aspect ratio.  Finally, the cylindrical 
shape was maintained by a circumferential sheath of fibers deposited around the outside. 
Fibrous microstructure. A section of the 6-0 collagen nerve guide viewed by SEM 
(Figure 15A & B) demonstrates the structure of the electrospun fibers around the microchannels.  
This microfiber mesh creates an open network of paths for nutrient transport into and out of the 
channel.  The fibers in Figure 15B show some artifact resulting from cutting.  Thus, fiber 
morphology can be better evaluated from a flat sheet of the electrospun fibers (Figure 15E).  This 
image shows smooth fibers of roughly uniform diameter.   The unraveling of the coil as seen in 
Figure 15A was addressed in later guides by an electrospun sheath (Figure 15C) which fixes the 
guide in the circular shape.  The circumferentially-oriented fibers of the sheath can be seen 
covering the layer of random fibers in Figure 15D. 
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Figure 15. SEM images of microchannels and microchannels in the nerve guides.(A and B) Transverse-
section of nerve guide with aligned channels at 25 and 650 X magnification.  (C and D) Outside of rolled nerve 
guide sealed with an electrospun sheath (Shown at 25 and 500 X magnification).  (E) Top view of randomly-
oriented fiber mat before rolling to form guide.  (F) Schwannoma cells on random fiber electrospun fibers inside 
nerve guide after in vitro culture.  Two cells are highlighted with circles. 
   
Primary and secondary channels. Multi-channel guides fabricated with a range of 
diameters are shown in Figure 16.  Figure 16A shows a nerve guide with 25 channels 
approximately 176 µm in diameter fabricated with 4-0 synthetic sutures.  Although not 
homogenous in shape or dimension, an equivalent number of secondary channels double the 
channel density.  Secondary channels adjacent to each primary channel were formed by the space 
between the primary channels and the flat mesh.  The size of these secondary channels is 
affected by the ratio of the two electrospun layers and the template diameter.  Secondary 
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channels provide additional space for cell migration, but due to the inhomogeneity of these 
structures we focus on the primary channel.  Figure 16B and C shows guides produced from 6-0 
collagen and synthetic sutures respectively.  Primary channels in these guides are more circular 
and the secondary channels more regular.  One 10-0 guide was made for the purpose of 
demonstrating versatility of this method (Figure 16D).  Only 10 channels were made since 10-0 
sutures are very short and it requires many sutures to obtain the same number as larger sutures.  
Since the layer thickness was not adjusted for this design, the channels contribute very little open 
area for nerve growth and no secondary channels are present.  As seen in the figure, 10-0 sutures 
do not act well as mandrels for rolling, resulting in loose rolling and the large central lumen 
observed in this figure.   Due to the manual steps involved with this process we recognize that 
there may be a minimum diameter that is feasible with the current technique.  Although, we do 
not think that this will hinder the success of our design, we hope to improve the precision with 
more automated techniques in the future. 
Channel diameter. Suture templating resulted in channel diameters 13 to 28 µm larger 
than the sutures used to create the channels.  We hypothesize that electrospun fibers are not 
attracted to the sutures and are not deposited tightly around them, accounting for the diameter 
differential.  Although initial work began with collagen sutures, synthetic sutures or fishing line 
were later used due to easier removal. 
Layer thickness. The thickness of each electrospun layer can have drastic effects on the 
structure and mechanics of the guide.  The mentality behind our design is to minimize the layer 
thickness to facilitate transport through the walls and maximize the number of microchannels 
available while still providing sufficient mechanical strength.  Figure 14D &E shows how 
thinner walls guides are less defined and more susceptible to deformation during cutting 
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compared to thicker guides in Figure 14F.  Consequently, future work to increase open areas 
designated for cell adhesion will focus on increasing template spatial frequency, not decreasing 
wall thickness.   
Porosity.  Porosity was estimated using geometric calculations based on mass and volume 
of the final guide and the density of the PCL (1.145 g/cm3).  These volume calculations were 
supported by similar values obtained via a second set of calculations that used the V1 and V2, the 
14% PCL polymer concentration, and the percent of the collector area used for making the guide.  
The total porosity and the percent contributed by the channels are reported in Figure 14.  All 
guides in this sample set showed porosity above 85 percent.  Additionally, void space between 
electrospun fibers contributed to the majority of porosity since the highest Pc was 16 percent.  
This supports the premise that our electrospun mats are highly porous and should be conducive 
to nutrient transport.  
Reproducibility. As with any fabrication process, reproducibility is important.  The 
current method contains two areas where variability can be introduced: electrospinning steps and 
manual steps.  Achieving stable and consistent electrospinning conditions is essential to 
producing repeatable guides.  Fiber diameter and morphology are known to be affected by 
electrospinning parameters which include acceleration voltages, polymer molecular weight, 
solution concentration, and humidity.  One electrospinning complication that may arise is the 
formation of globs or nets of fibers depositing on the collector.145  These do not form tightly 
around the template and cause defects in the design.  A second variation that can greatly 
influence the outcome of templated guides is uneven distribution fibers on the collector.  If 
uneven deposition occurs, some regions will be thick while others are thin and weak.  To 
facilitate more uniform distribution, the collector may be slowly moved during electrospinning.   
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Rolling the flat sheet to form the cylindrical guide is the primary step in which manual 
variation can affect the outcome.  As is evident in Figure 16A & D, a large central lumen is 
formed if the guide is not rolled tight enough.  Contrarily, if the guide is too tight, compressive 
forces deform the channel shape when the template is removed.  This is especially significant for 
guides with thin layers (Figure 14D).  Additionally, template alignment is important for 
maintaining uniform spacing between channels.   
Reproducibility can be achieved by maintaining consistent conditions between samples.  
These include electrospinning parameters (acceleration voltage, solvent and concentration of the 
polymer solution, distance, flow rate, humidity), thickness of fibrous mat, template size and 
spacing, and rolling tightness.  Three guides produced by the same electrospinning and template 
conditions were imaged and shown in Figure 14A-C to demonstrate reproducibility of this 
method.  The channel shape and overall quality of the guides becomes more vulnerable to cutting 
damage as the layer thickness decrease.  This is evident in the bottom panel (Figure 14D-F) 
where channels become more defined as the layer thicknesses increase. 
Fabrication time. The time required to fabricate guides using this technique include both 
electrospinning and templating times.  Electrospinning time depends on the rate of spinning and 
the volume spun.  This step can range from approximately 5-30 minutes accordingly.  The 
templating step depends on the number of templates used.  Template stringing time is 
approximately five per minute.  This can vary depending on the size of the template and the skill 
of the person. 
Versatile fabrication process 
Synthetic nerve guides offer two advantages over autografts and allografts: availability 
and customizability.  Our method of electrospinning with micro-templating demonstrates 
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customizability in many aspects of the design.  Electrospinning is a versatile technique that 
allows tailoring of the fiber diameter and alignment by changing solution and process parameters 
146.  Collagen and synthetic sutures of various sizes (6-0, 7-0, and 10-0) were used to 
demonstrate the ability to form channels with diameters ranging from 33-176µm (Fig 4).  The 
available templates could theoretically be expanded to produce channels over the range of 
available template diameters: 10 µm with 11-0 to 800 µm with 6-0.   However, as mentioned 
previously, we do not expect to be working in this range.   
The number and spacing of sutures can also be altered to match the fascicle geometry of 
the nerve being replaced.  Diameter and length of the guide can be increased by electrospinning 
wider meshes on larger collectors.  Finally, this method is applicable with any electrospun 
polymer, where the stratified fabrication method permits different polymer to be used for each 
layer.   Since electrospinning solutions can incorporate functional proteins or cells, we may be 
able to match mechanical properties or incorporate biochemical cues.140, 147, 148 
Fiber diameter. Parameters for fiber and channel diameter have yet to be optimized for 
our nerve guide.  The size of the fibers with respect to that of the cell can affect how the cell 
senses and interacts with the substrate.42  The current electrospinning parameters produce a 
random mesh approximated by ImageJ measurements to be 2µm diameter fibers (Figure 15E).  
Control of diameter was not the focus of this work, but significant existing literature can be 
referenced to tightly control and measure diameter distribution over wide range. Endoneurium, 
perineurium, and epineurium of native nerve all contain bundles of longitudinally-aligned 
collagen fibrils ranging from 25-100nm in diameter.149  However, prior work studying nerve and 
Schwann cell migration on longitudinally-aligned fibers demonstrates that some directional 
control may be lost with the use of very small fibers (293nm) and that larger fibers (759 and 
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1325 nm) yield quickest migration.  Thus, while fiber diameter for the current design may affect 
the cell attachment and infiltration, future work involving incorporation of aligned fibers within 
channels will rely heavily on a diameter that is optimal for topographical guidance. 
Channel diameter.  From existing literature, it is unclear whether channel diameters near 
that of fascicles (200-400µm) or individual axons (2.5-22µm) are more conducive to axon 
regeneration.150, 151  Prior work has not demonstrated statistically significant differences for 
axonal growth depending on channel size.152  Although previous work with multi-channel guides 
showed that channels of small (12µm & 19µm) and (105 µm) medium diameter both supported 
rapid axon growth, small channels also restricted Schwann cell infiltration.152  Consequently, our 
current method using medium-sized channels around 100µm may be appropriate.  
 
Figure 16. Optical images of multi-channel guides with varying channel diameters.The various guides are 
not optimized, but rather are used to demonstrate the different diameters achievable using the templating method. 
Nerve guide fabricated with: (A) 4-0 synthetic sutures (150µm) to produce channels 176 ± 39 µm in diameter; (B) 6-
0 collagen sutures (100µm)  to produce channels 117 ± 11 µm in diameter;  (C) 6-0 synthetic sutures (70µm) to 
produce channels 98 ± 9 µm in diameter; and  (D) 10-0 synthetic sutures (20µm) to produce channels 33 ± 6 µm in 
diameter.  Scale bar = 500 µm. 
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Electrospun fibers permit Schwann cells to populate the guide  
These guides were designed for application in peripheral nerve repair, so initial in vitro 
work was performed with Schwann cells.  Schwann cells are critical to creating a permissive 
environment preceding nerve repair via phagocytosis of debris, deposition of basal lamina, and 
release of neurotrophic factors.113  Although it is controversial whether Schwann cells precede 
axonal regeneration153 154or follow axons into a lesion site155, 156, Schwann cells are intricately 
involved in the regenerative process. For these reasons, tissue engineering approaches to nerve 
repair have incorporated Schwann cells from a variety of sources including autologous, 
allogeneic, cell lines, or stem cells.113  Consequently it is important that Schwann cells respond 
appropriately to the environment created by our nerve guide. 
We demonstrated the feasibility of our design using PCL since it can easily be 
electrospun.  Since PCL is a component of FDA-approved nerve guides, Neurolac, and has been 
established as a suitable biomaterial from prior peripheral nerve research112 in vitro 
biocompatibility tests were not repeated in this research.  We aimed simply to demonstrate that 
Schwann cells infiltrate into the interior of the guide along the microchannels. While PCL 
exhibits slow degradation which may be suitable for the slow regeneration of nerves157, we 
acknowledge that high hydrophobicity and lack of functional groups may preclude PCL from use 
in our final design. 
Guides for all in vitro culture were coated with laminin prior to cell seeding.  PCL alone 
does not contain any functional groups or bioactive domains for cellular recognition.  However, 
in the body most foreign surfaces are quickly coated by natural protein adsorption.  To mimic the 
adhesion sites present in vivo, nerve guides were coated in laminin, a protein known to improve 
Schwann cell adhesion, proliferation, and survival.158   
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SEM. Schwannoma cell adhesion and morphology on the fibrous electrospun substrate 
were observed after 8 days in culture.  Images from SEM (Figure 15F) show the morphology of 
these cells on random electrospun fibers of the nerve guide interior.  Cells on the random fibers 
appear to have rounded cell bodies sprawled out on top of the fibers.  Cells adhere to random 
fibers via extension of several processes per cell but do not show any directional preference.   
MTT. MTT results from seeded guides show absorbance readings close to that of one 
million cells.  Actual MTT activity may be higher since the guide still contained areas of deep 
purple color that could not be freed despite mechanical disruption.  This suggests that cells are 
not only alive but metabolically active.  However, analysis of these results should consider that 
histology shows a high density of cells on the outside of the guide (Figure 18C & D) and that 
MTT cannot provide insight on location of metabolically active cells.  Furthermore, thick layers 
of Schwann cells becoming overconfluent in aggregates may begin to change phenotype and also 
skew results. 
Live/Dead/DAPI.  Live/Dead solutions were added to guides at 4 and 11 days (Data not 
shown).  A layer of live cells were identified around the outside of the guide and only a few dead 
cells were seen evenly distributed throughout the entirety of the guide.  DAPI staining showed 
many more cells distributed throughout the central region of the guide.  We believe that the 
majority of the cells are alive but lack staining by the calcein AM since it is hydrophobic and 
likely adsorbed by the large surface area of PCL fibers.   The staining of dead cells throughout 
the guide suggests that the more hydrophilic nature of the ethidium homodimer permits it to 
diffuse more freely.  Consequently, the Live/Dead staining was not useful for characterizing cell 
growth in our guides. Thus MTT was used for quantification while DAPI staining was used to 
qualitatively inspect distribution and number. 
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Figure 17. MTT absorbance at 540nm  MTT was solubilized in DMSO following conversion by cellular 
metabolism. Absorbance readings were measured in triplicate for each sample (n=3). 
 
DAPI staining from longitudinal images reveal that Schwannoma cells can populate the 
entire length of the nerve guide (Figure 18C).  By inspection, an increase in cell density can be 
observed from day 4 to day 11.  This suggests cell proliferation within the guide channels, 
including the mid-section which has the least access to fresh media.  Schwannoma cell migration 
and proliferation throughout the entire guide is further supported by increased cell density 
throughout channels in the transverse-sections of the nerve guides at the ends (Figure 18 B & D).  
These reveal that Schwannoma cells primarily reside within the channel lumens and gaps 
between layers with less penetration into the fibrous walls.  This distribution pattern of cells 
within channels is also seen in longitudinal sections in Figure 18C.  The localization of cells 
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within the channel is consistent with literature reporting the scarcity of cell penetration into the 
interior of electrospun meshes.159  
 
Figure 18. DAPI staining of Schwannoma cell nuclei in the multi-channel nerve guide.(A) Longitudinal 
section after 4 days in culture.  (B) Transverse section at open end after 4 days in culture.  (C) Longitudinal section 
after 11 days in culture.  Asterisk indicates tear caused by sectioning. (D) Transverse section at open end after 11 
days in culture.  Note: Fluorescent look up table (LUT) was adjusted to make nerve guide visible. 
 
We believe that the high surface area and porosity offered by electrospun structures 
enhances the cell penetration along the channels of the nerve guide.  Additionally, open space 
offered by the channels provides regions of low growth resistance that serve to direct axons 
toward a single distal target.  As supported by the in vitro cell culture, the diffusion permited by 
this fibrous mesh permits cell proliferation within even the central-most interior of the nerve 
guides (Figure 18).  Additionally, the small size of voids between electrospun fibers restricts 
most cells from migrating into channel walls and minimizes influx of inflammatory cells from 
the surrounding tissue upon implantation.  Electrospun fibers strike the balance between high 
interconnectivity that allows good mass transfer and small pathlength that confines Schwann 
cells and nerves within the channels. 
 
 40 
Future work 
This work is the first step in demonstrating a new design of synthetic nerve guides.  Like 
any new technology, there are aspects awaiting further investigation.  Two modifications that we 
believe are crucial involve transitioning to a more suitable biomaterial and automating the 
fabrication.  Alternatives to PCL will be pursued in the future to increase hydrophilicity, 
introduce cell adhesion sites, and broaden degradation profile to match clinical needs.  Ten-cycle 
compressive tests (not shown) demonstrate hysteresis after an initial plastic deformation.   Thus 
to prevent channel collapse in future designs we will use an elastomer such as poly(glycerol 
sebacate) that increases elastic recovery.160 
Variability introduced during the manual steps is a limitation that may be addressed using 
robotics in the future.  Current methods involve templates that are extremely small and difficult 
to handle.  Automating the process in the future should not only improve reproducibility, but also 
increase the channel density that can be achieved. 
3.1.4 Summary 
This work presents a new electrospun construct containing a high density of aligned 
microchannels mimicking the fascicles in nerve.  We demonstrate a high number of channels of 
defined size and shape within a porous structure.  We believe these features distinguish our 
design from existing ones.  We also demonstrate the repeatability and versatility of this method 
and begin to characterize cellular response.  We will continue to focus on translating this 
technology into clinically-useful products by testing the guides in a rat sciatic nerve model.  
Results from a pilot implantation demonstrate that the guide can anastamosed with 10-0 suture 
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and maintains its shape without unrolling.  In the future, we will couple this design with 
stimulatory cues such as aligned fibers within the aligned channels and growth factors. 
3.2 INCORPORATION OF LONGITUDINALLY ALIGNED FIBERS WITHIN 
CHANNELS OF FIBROUS NERVE GUIDE 
3.2.1 Introduction 
Topographical guidance cues 
Literature reports that aligned fibers can provide direct paths to guide axon growth cone and 
Schwann cell migration.132, 135, 161-165  Additionally, parallel fibers may be involved in the 
differentiation/maturation of neural stem cells and Schwann cells.134, 166, 167  As summarized in 
the review by Spivey et al, “Clinical evidence suggests that nano- and microtopography 
incorporated into scaffolds does not merely improve peripheral nerve regeneration, but is in fact 
a prerequisite for meaningful restoration of nerve function.”168 Thus, topographical cues are 
especially important for enabling large gap regeneration. Despite promising results in 2-
dimensional studies, incorporation of parallel fibers into 3-dimensional constructs has proven 
difficult by traditional electrospinning methods.139 
Several types of nerve guides have been designed to incorporate aligned fibers, with 
recent results favoring highly open architectures.  The simplest method to incorporate aligned 
fibers into a 3-D nerve guide is to fill the lumen of a conduit with a bundle of aligned fibers 
(Figure 19A).30, 139, 169-175  This approach results in dense fiber packing, which impedes cell 
infiltration113, 161 and reduces total axon number.176   The second most common method is to line 
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the inner surface of a luminal conduit with aligned fibers (Figure 19B).132, 136, 177-179  This 
approach benefits regeneration but does not maximize surface area for topographical guidance.  
To increase surface area, a third option places one to three aligned sheets in a conduit at low 
packing density (Figure 19C).141, 180    Promising results from these designs also favored low 
fiber density since single-sheet designs regenerated more axons and out-performed three-sheet 
guides.141 
 
Figure 19. Incorporation of aligned fibers in existing (a-c) and proposed (d-e) nerve guides (a) High 
density of longitudinally-aligned fibers packed into lumen. (b) Longitudinally-aligned fibers line the lumen, but 
leave most of the cross-section open. (c) Stacked sheets of aligned fibers are placed in the lumen of the guide to 
provide greater topographical surface area. (d) Incorporation of microchannels into lumen of parallel fibers is 
difficult because low fiber entanglement allows fibers to slide, causing channel collapse. (e) Aligned fibers line 
multiple microchannels of nerve guide to provide high surface area of topographical cues. 
 
Challenges to fabricating aligned fiber guide 
Our goal was to: 1) incorporate high surface area of aligned fibers into a 2) highly-open 
nerve guide to mimic native nerve architecture. The initial approach to add channels to a fiber-
filled lumen (Figure 19D) proved difficult since an entire guide of aligned fibers has low fiber 
entanglement, causing channels to fall apart.  Thus, our criteria were amended to include: 3) 
sufficient structural integrity to avoid channel collapse.  This was accomplished by fabricating 
channel-filled guides (Figure 19E) where aligned fibers line the lumens of microchannels, held in 
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place by random fiber mesh.  We adapted our previous templated electrospinning technique to 
incorporate aligned fibers.181  Slowly degrading polycaprolactone (PCL) fibers were aligned to 
provide sustained guidance while poly (lactic glycolic acid 50:50) PLGA fibers provide 
structural support until fibrin and extracellular matrix (ECM) are deposited. 
 
3.2.2 Experimental Section 
Materials 
A nerve guide was constructed of electrospun polycaprolactone (PCL) and poly (lactic glycolic 
acid 50:50) PLGA fibers.  A 14% PCL (Mn=80,000 Sigma-Aldrich Corp, St. Louis, MO) 
solution was prepared in 5:1 trifluoroethanol (TFE):H2O and 15% PLGA 5050-DLG-9A 
(Mn=168,000 Evonik Degussa Corporation, Birmingham, AL) was dissolved in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP).  A custom parallel plate collector was used to collect fibers and 
string templates during fabrication (Figure 22(a)).   It was constructed by placing two short 
pieces of aluminum orthogonal to parallel collector plates to maintain a specified distance during 
electrospinning and fabrication.  Combs attached to the long sides of the parallel plate collector 
were used to keep templates in place as they were strung.  The templates used for this design was 
130µm diameter Trilene 2lb fishing line (Berkley, Spirit Lake, IA).  This is much less expensive 
than sutures (as previously used) yet low friction for easy removal.   
Electrospinning 
Aligned PCL fibers were electrospun onto a parallel plate collector (Figure 20.1).  
Templates were strung parallel to the PCL fibers by weaving onto the combs (Figure 20.2).  A 
second layer of aligned PCL fibers were electrospun on top of the templates (Figure 20.3).  The 
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aligned fibers were then cut between templates with a scalpel to create openings (Figure 20.4).  
This caused the PCL fibers to form bundles around the template and created space for the PLGA 
layers to interact.  Random PLGA fibers were electrospun to each both sides of the collector to 
hold the bundles of aligned fiber/channels in place (Figure 20.5).  This was done by holding the 
parallel plate in front of a grounded razor.  The templates were cut, and the composite rolled up 
(Figure 20.6).  A thin sheath was deposited around the perimeter of the guide by electrospinning 
15 µL PCL solution while rotating (60 rpm) the construct directly in front of a grounded razor 
blade (Figure 20.7).   It was then placed in a vacuum oven at 45oC for 24 hours to remove excess 
solvent.  The templates were then removed and the guide trimmed to size (Figure 20.8). 
 
Figure 20. Schematic of nerve guide fabrication(a) with light microscope images of fibers and templates 
(b) and electrospinning parameters (c).  1) Aligned PCL fibers were deposited across gap of open collector by 
electrospinning.  2) Template was attached to collector parallel to PCL fibers.  3) Aligned PCL fibers were 
electrospun on top of template. 4) The PCL fibers were cut between templates with scalpel so PLGA layers in the 
next step could bind.  5) PLGA was electrospun to front and back to hold bundles of aligned fibers and templates 
together.  6) The composite was removed from the collector and rolled up.  7) A PCL sheath was electrospun around 
the outside to prevent unraveling.  8) After removing the solvent in a vacuum oven at 45oC for 24 hours, the 
templates were pulled out and guide trimmed to size. (Scale bar:500µm). 
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Scanning Electron Microscope (SEM) 
Samples were soaked in water and frozen on dry ice before cutting with a scalpel to 1-
2mm transverse slices.  The samples were then dehydrated in a desiccator overnight before 
sputter coating with 3.5nm gold with a Cressington Sputter coater.  A Jeol JSM-6330F SEM was 
used to image the samples at 3kV acceleration voltage. 
Image Analysis 
Fast Fourier transform (FFT).  Fiber alignment was quantified as described by Corey et 
al.162  Briefly, FFT analysis was performed on greyscale images in ImageJ using the “FFT” 
function under “Process”.  The FFT output image was rotated 90o to account for phase shift in 
transform to match SEM image. Radial summation of pixel intensity of FFT images was 
performed by selecting the FFT image with the circle tool and running the “Radial profile” plug-
in (360o, radial sums).  Due to symmetry of FFT, 180o was plotted (Figure 22C) with peak 
alignment centered on 0o.  The full-width half maximum (FWHM) was reported as a single index 
of fiber alignment.  It is measured by the width of a function at half the height (peak-to-valley).   
Fiber Diameter.  Fiber diameter was quantified in ImageJ by drawing a horizontal line 
across the SEM image and measuring at least 30 fibers intersecting this line. 
Channel analysis.  Image analysis was performed on binary images of SEM cross-
sections using Nikon NIS-Elements software.  Three cross-sections with minimal cutting 
artifacts were selected for analysis.  Channel area was measured by using the region of interest 
(ROI) tool to select channels by autodetect or by manually tracing.  The ROI selection tool was 
also used to measure the area and perimeter for the whole construct.  Assuming a circular shape, 
diameter and perimeter were calculated from the area for each channel.    These values were used 
to determine the channel area percentage and surface area ratio by the equations shown below.  
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The first value reflects the open area of the guide available for cell infiltration.  The surface area 
ratio represents how much more surface area of aligned fibers is provided by the multi-channel 
design than a single lumen design for a construct of equivalent length. 
 Equation 1. 
  Equation 2. 
Cell infiltration and attachment 
Control guides. Cell infiltration into our experimental nerve guides was compared to 
control guides which contained longitudinally-aligned PCL fibers without channels.  Aligned 
PCL was electrospun to open collectors as previously described in 200 µL intervals and rolled 
such that fiber alignment was parallel to the longitudinal axis.  This was repeated until the 
diameter of the construct was equivalent to the experimental guides (approximately 1.75 mm).  A 
sheath was electrospun around the outside using the same technique described for the 
experimental guides.  
Cell seeding in fibrin.  Rat Schwannoma cell line RT4-D6P2T (ATCC CRL-2768) were 
trypsinized and resuspended in 3 mg/mL fibrinogen (Sigma F8630) solution at 2 X 106 cells/mL.  
A 90 µL fibrinogen/cell solution was added to 10 µL thrombin (Sigma T4648) solution (2 
mg/mL) and pipetted into the end of each segment of  nerve guide (1.5-3.5mm length).  The 
fibrin quickly gelled within 30 seconds and 2 mL Dulbecco’s modified eagle medium (DMEM) 
(ATCC 30-2002) with 10% fetal bovine serum (FBS) and 1% antibiotic/antimycotic (Cellgro 30-
004-Cl) was added to each guide in a 12-well plate.  Cells were cultured for 24 hours in a 37oC 
incubator at 5% carbon dioxide. 
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DAPI Staining.  Guides were removed from media and fixed in 10% buffered formalin 
(Fisher Scientific SF100-4) for 15 minutes.  They were then washed in deionized water before 
freezing in Tissue-Tek O.C.T compound (VWR 25608-930).  Slides were prepared by cutting 50 
µm longitudinal sections on a microtome and staining with DAPI mounting media (Vectorlabs 
H-1500).  Images were captured on a Nikon Eclipse Ti inverted microscope. 
SEM Imaging.  Samples were fixed in 10% formalin for 15 minutes before washing in 
deionized water.  They were then serially dehydrated by soaking in 100% ethanol, 3:1 ethanol: 
hexamethyldisilazine(HMDS), 1:1 ethanol:HMDS, 1:3 ethanol:HMDS, 100% HMDS for at least 
15 minutes each.  Samples were cut with a scalpel, placed on SEM stubs, and imaged with SEM 
as described above. 
3.2.3 Results/Discussion 
Biomimetic architecture 
We designed nerve guides to mimic native nerve architecture and achieved a cross-sectional 
pattern for our electrospun nerve guide (Figure 21A&C) that is almost indistinguishable from 
decellularized nerve (Figure 21B&D) [images: courtesy Dr. Tatsuo Ushiki, M.D, PhD, Niigata 
University Graduate School of Medical and Dental Sciences].  Both contain a high number of 
channels surrounded with thin fibrous walls.  It should be noted that channel diameter in our 
guide are approximately 30 fold larger than those in the decellularized nerve image.  We chose 
130 µm diameter based on existing literature suggesting that large channels are sufficient and 
likely preferable152, 182 although the same technique could be translated to smaller channel sizes.  
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Figure 21. SEM images showing structural resemblance of(a,c) electrospun nerve guide to (b, d) 
decellularized nerve (images: courtesy Dr. Tatsuo Ushiki).  Adapted for reprint with kind permission from Springer 
Science and Business Media 183.  Note the scale in electrospun images is larger than that of decellularized nerve. (a: 
150µm, b: 5µm, c: 40 µm, d: 2 µm)  P- perineurium. En-endoneurium.  Arrowhead- c: aligned PCL fibers lining 
microchannel wall- d: longitudinally arranged collagen fibers. 
 
Immobilization of aligned fibers for a stable structure 
As described previously, a significant challenge of using aligned fibers for scaffolds is 
their tendency to fall apart due to low entanglement.  We developed an innovative approach to 
secure the aligned fibers and maintain intact channels throughout the production process and in 
the final product.  Fabrication is performed on custom-designed parallel plate collectors with 
three features that are key to this process.  Firstly, the parallel plates offer a simple method to 
create aligned fibers without using rotation or transferring fibers from a mandrel.  This is 
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supported by literature reports where parallel plates are used to electrospun aligned fibers of 
poly(lactic acid), polyamide-6, poly(ethylene oxide), PCL:collagen blends, or poly(vinyl 
alcohol).184-188   Secondly, there is an aligned-to-random  transition that occurs at the collector 
edges as discussed in the paper by Xie et al.189  These random fibers help to hold the aligned 
PCL fibers in place until the fabrication is complete, after which they are cut off and discarded.  
Finally, the open collector permits electrospinning to both sides of the guide, resulting in better 
PLGA interaction and thinner walls than the flat plate method.  The slits between aligned fibers 
were also crucial to allowing random PLGA fibers to bind and hold the bundles of parallel 
fibers/templates in place.    
Aligned fibers are suitable for topographical guidance 
The emphasis of this paper is the presentation of aligned fibers to cells to present 
topographical guidance in an open architecture to facilitate cell infiltration and neurite 
outgrowth.  Thus fiber alignment is quantified to demonstrate directional preference.  Fiber 
diameter is measured to ensure that it falls within the optimal range established in the literature. 
Alignment.  The aligned region of electrospun PCL can be distinguished from the random 
PCL fibers visually (Figure 22B&C).  The FWHM values obtained by FFT of SEM images were 
used to quantitatively compare alignment fiber alignment.  Fibers in the aligned region produced 
a FWHM value 1.6 times of random fibers.  Although we did not establish criteria for minimal 
alignment, the FWHM value could be used in future designs to set a standard for alignment and 
ensure reproducibility. 
Diameter.  Average fiber diameter for the random and aligned regions of PCL were 
calculated to be 86 and 60 µm respectively.  Prior literature suggests that neurite and Schwann 
cell migration are best directed by 5µm fibers compared those of larger diameters (30, 100, 200, 
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500) but also prefer 1.33 and 0.76 µm fibers over 0.29 µm fibers.161, 190 Thus, fibers in the range 
of 0.76 µm to 5 µm should be appropriate for providing guidance cues.  Additionally, the 
random PLGA fibers used for structural support were of larger diameter, resulting in larger pore 
sizes between fibers to permit greater cell infiltration. 
High surface area for topographical guidance.  By lining 58-72 microchannels with 
aligned fibers, the guides offer 5.6 times more surface area than single-lumen guides of 
equivalent length and diameter as estimated by equation 2.  This guidance is expected to reduce 
aberrant growth and shorten time to recovery.   
 
Figure 22. Fiber collection on parallel plate collector.(a) Parallel plate collector maintained at fixed width 
by two perpendicular spacers. Dimensions of gap region were 4cm X 18cm.  Note the edges of the long sides have 
been sharpened to a triangular edge for better fiber collection.  Combs were attached to each side for template 
fixation.  Electrospun PCL fibers were deposited randomly on the aluminum (b) and aligned across the gap (c).   (b) 
SEM of random PCL fibers deposited on aluminum parallel plate of open collector [Insert: FFT of fiber SEM] (c) 
Aligned PCL fibers span gap between parallel plates.  [Insert: FFT of fiber SEM], (d) SEM of random PLGA fibers, 
(e) SEM of random PLGA fibers [arrowheads] on top of aligned PCL fibers [arrow] (f) Graph of average pixel 
intensity in radial direction of FFT images adjusted to center around 0o,(g) Average fiber diameter of PCL and 
PLGA used in scaffold preparation.  (Scale bar: b-e: 10 µm). 
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Open architecture for cell infiltration 
Nerve guides constructed simply by filling conduits with aligned fibers may obstruct 
cellular infiltration.  In contrast, our nerve guides offer 51% open space by reducing channel wall 
thickness and limiting aligned fibers to channel perimeters.  The thickness of PCL and PLGA 
layers were adjusted to minimize wall thickness while maintaining strength to prevent channel 
collapse.  In most channels, the wall is less than 20 microns.  This will provide much more area 
for cell infiltration than our previous design (25% open)181 and improve transport of nutrients 
and waste. 
 
Figure 23. Analysis of SEM images of 3 samples representative of nerve guide architecture.(a) A high 
number of microchannels can be observed.  (b) Individual channel dimensions were measured to determine channel 
number, channel diameter, surface area ratio, and channel area percentage.  (Channels highlighted in yellow, guide 
perimeter outlined in red)  Table shows average values for 3 cross-sections ± standard deviation.  (Scale bar: 
100µm). 
 
 
 
 52 
Schwannoma cell culture 
In vitro experiments were performed to test our hypothesis that the open design of our 
experimental guide was more conducive to cell infiltration than control guides without channels.  
Additionally, aligned fibers would provide topographical cues to cells.  Cells were seeded in both 
guides with fibrin gel to mimic the natural fibrin bridge that forms in guides during regeneration.  
Closed architecture of control guides without channels 
Control guides fabricated by methods described in Figure 19A contained longitudinally-
aligned fibers but no channels.  This method produced a closed cross-sectional structure with 
only a few open regions observed between layers (Figure 24A).  The tight fiber packing can be 
observed clearly in Figure 24B&C, corresponding to cross-sectional and longitudinal sections of 
the control guides. 
Fiber alignment promotes cell elongation 
Cells in both guides exhibit elongated cell bodies when attached to the aligned PCL fibers 
(Figure 24D &F) while remaining more rounded on the random PLGA fibers (Figure 24E).  This 
change in cell shape suggests that topographical cues are directing cell morphology.  We 
anticipate that these cues will increase Schwann cell infiltration while also directing neurite 
outgrowth during regeneration. 
Open architecture permits cell infiltration 
The experimental guides show a moderate number of cells distributed evenly throughout 
the guide (Figure 24G).  In contrast, the control guide shows only a few cells that are restricted to 
the gaps between layers (Figure 24H).   
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Figure 24. Results from Schwannoma cell culture on experimental and control nerve guides.(a-c) SEM of 
control nerve guide.  (a) Cross-section of guide shows some openings between layers of aligned fibers. (b) 
Magnified cross-section from (a) showing aligned fibers with limited space for cell infiltration. (c) Longitudinal 
slice of guide showing fiber alignment along axis.   (d) SEM showing Schwannoma cells elongated along PCL fibers 
in experimental guide.  Some fragments of PLGA fibers are also present and may have broken during the 
dehydration/cutting steps.  (e) SEM of Schwannoma cells on larger random PLGA fibers in experimental guide.  (f) 
SEM of Schwannoma cells elongated on PCL fibers in control guide.  Underlying fibers may be coated with fibrin.  
(g&h) Schwannoma cells seeded into nerve guides are characterized by DAPI staining.  (g) Longitudinal section of 
experimental guide showing Schwannoma cells distributed throughout the guide.  (h) Longitudinal section of the 
control guide showing few Schwannoma cells that are restricted to gaps between layers.  Arrow indicates direction 
of fiber alignment and dashed circles identify cells. (Scale bar: a:100 µm,  b-h: 10 µm). 
 
Limitations and future work 
Collector Limitations 
Several collector modifications were identified that could contribute to greater alignment 
and uniformity in the future.  For instance, the open collectors were machined from aluminum 
rods and contained edge defects.  In the future, the edges could be polished to remove 
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imperfections and increase alignment. Additionally, the combs attached to the collector protrude 
slightly and interfere with the PLGA deposition near the ends of the guide.  Thus, approximately 
1cm of the guides were trimmed from each end and discarded to remove these inhomogeneous 
regions.  With a collector gap of 4cm, this leaves 2cm remaining of useable guide.  We anticipate 
that these wasted regions can be minimized by laser cutting collectors from metal stock.  Finally, 
there may be a maximum limit to the gap size across which fibers can form, limiting the size of 
nerve guides that could be fabricated by this method.   
Reproducibility of channel linings 
The current fabrication method is labor intensive and varies by operator.  Figure 25 
depicts SEM cross-sections of individual channels showing the desired lumenal lining as well as 
collapsed lining, delaminated lining, and no lining.  These defects likely result from manual 
removal of the template and could introduce variability.  The number of channels per guide also 
varies some since secondary channels can be formed between layers as a result of rolling while 
other channels may collapse under sufficient forces.  A benefit of using the multichannel 
approach is that with the unfortunate collapse of or occlusion of a few channels should not result 
in complete failure of the guide due to remaining channels.    Soluble templates are currently 
being investigated to allow the ends to be cut off with the physical template still in place and also 
reduce the chance that aligned fibers are disrupted during template removal. The high porosity of 
the guide should facilitate the dissolution and removal of template materials.  The overall 
reproducibility of this type of guide will need to be improved before clinical translation and 
could benefit from the precision and reliability of robotic manufacturing. 
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Figure 25. SEM of channels showing the microchannels lined with parallel fibers(a) lumenal lining, (b) 
collapsed lining (c) delaminated lining, or (d) no lining. (500X magnification) 
3.2.4 Summary 
We demonstrated a new technique to distribute aligned fibers within a 3D nerve guide that 
mimics the native architecture.  The guide has thin walls and high channel number to maximize 
surface area without obstructing infiltrating cells.  To fully test the benefits of our design will 
require in vivo testing.  We anticipate this approach can be applied to other materials to match 
mechanical and degradation properties to improve nerve regeneration. 
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4.0  COMBINING FDM WITH TEMPLATED ELECTROSPINNING FOR 
MICROVASCULAR SCAFFOLDS  
Chapter Aim 
Prior work demonstrated constructive remodeling of acellular poly(glycerol sebacate)(PGS) 
vascular grafts in situ.191, 192  We hypothesized that this regenerative process could be 
extrapolated to the microvasculature and used to perfuse TE scaffolds.  The aim of this chapter 
was to pattern electrospun scaffolds with capillary-like branched templates that can be rapidly 
endothelialized.  Electrospun poly(dioxanone) (PDO) was used as the scaffold material since 
electrospun PGS was being developed in parallel (Aim 3).  An FDM printer was used to make 
branched templates with greater versatility and automation than the sutures in Aim 1.  
Additionally, nontoxic water-soluble poly(vinyl alcohol) (PVA) templating material enabled 
easy removal.  Feasibility of endothelializing these of microvascular scaffolds was established in 
vitro. 
Background 
Sufficient vascularization is a ‘major bottleneck’ of solid organ tissue engineering and 
achieving it has even been called the ‘holy grail of tissue engineering’.2, 11  Transplanted cells 
often die from lack of oxygen and accumulation of waste. This is especially true for those with 
high metabolic activity such as neurons,193 hepatocytes,194 and cardiomyoctes.5, 195   
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There is extensive literature describing existing approaches to vascularize TE 
constructs.1, 6, 196-201  Vascularization is critical for maintaining cell survival by providing 
effective nutrient delivery and waste removal beyond the 200 µm diffusion limit.4, 5  Although 
angiogenic factors can induce sprouting of vessels into ischemic tissue, this slow (~ 0.1 mm per 
day) “extrinsic vascularization” (Figure 26) can take months to perfuse large organs, eliciting 
necrosis within the core.1, 199  Even organs with a pre-formed internal vasculature can take up to 
8 days to perfuse by inosculation (Figure 27).202  Consequently, an intrinsic network (Figure 28) 
that can be sutured to host vessels is needed to provide immediate perfusion upon 
implantation.199  Current sources of intrinsic vascular networks rely on harvesting vascularized 
pedicles from donor sites.   
Summaries of current approaches are summarized below: 
Porous or microfabricated scaffolds can facilitate cell ingrowth and vessel organization to 
hasten the slow extrinsic vascularization process.  Methods for fabricating these scaffolds 
include photolithography, microcontact printing, micromolding, and laser direct writing.1    
 
Figure 26. Extrinsic Vascularization.  Reproduced from 199 
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Coculture of endothelial cells with fibroblasts and other perivascular cells can form stable 
pre-formed vasculature in vitro.  Coculture methods can also be combined with microfabrication 
methods such as the InVERT method.203  However most coculture methods rely on inosculation 
since they are too weak to directly anastamose with host vessels.    Additionally, low mechanical 
properties of immature cellular constructs hinder load-bearing applications.96, 204, 205  
 
Figure 27. Inosculation.  Reproduced from 199 
 
Prevascularization of a scaffold utilizes intrinsic sprouting from an arteriovenous loop 
(AV) implanted in a donor site. 206, 207  The presence of the vessel within the core of the construct 
permits rapid vascularization.  Once established, this construct can be surgically removed and 
anastamosed at the target site.208  While this is an effective method,209 major drawbacks include 
the time and additional surgical site required to mature these in vivo.1, 208 
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Figure 28. Intrinsic Vascularization.  Reproduced from 199  
4.1 MICROVASCULAR SCAFFOLDS MADE BY COMBINED FUSED 
DEPOSITION MODELING AND ELECTROSPINNING 
4.1.1 Introduction 
Vascular networks within TE constructs have been developed through techniques 
including soft lithography,60, 61, 210-219 cast hydrogels,102, 220-227 coculture,228-230 and solid freeform 
fabrication (SFF).85, 231-240  Recent advances in these methods have made strides toward building 
3D constructs, improving porosity, and incorporating different cell types.61, 203, 220  However, 
shortcomings such as low mechanical strength (hydrogels),204 limited diffusion through thick 
solid walls separating microvessels from parenchyma (soft lithography),61 and nondegradability 
(poly(dimethylsiloxane) (PDMS)-based method) still hamper direct anastomosis and perfusion of 
TE constructs after implantation.      
We address these issues by introducing a new technique that uses fused deposition 
modeling (FDM) as an indirect method to pattern vasculature networks within electrospun 
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scaffolds.  The electrospun polydioxanone (PDO) scaffolds are strong and suturable, to allow 
direct anastomosis with host vessels.  Additionally, electrospun fibers offer high porosity and 
surface area to permit diffusion and promote cell attachment, respectively.241  Furthermore, PDO 
resorbs within 6 months.242, 243  Feasibility of endothelializing these vascular networks is 
demonstrated by in vitro culture and perfusion. 
4.1.2 Experimental Section  
Micropatterned Template and Scaffold Fabrication 
Fused deposition modeling.  A FDM printer (AO-101, Lulzbot, Loveland, CO) was used to 
extrude capillary networks from 3 mm poly(vinyl alcohol) (PVA) filament (Ultimachine, South 
Pittsburg, TN) (Figure 29A-C). Printing was performed at 210°C nozzle temperature and 120°C 
bed temperature.  Designs for the micropatterned template were written in G-code and optimized 
to maximize template uniformity and reproducibility.  The printer was run using Pronterface 
open-source program.  
Electrospinning. PDO (Sigma-Aldrich, St. Louis, MO) was dissolved in 1,1,1,3,3,3-
hexafluoroisopropanol (HFIP, Oakwood Products Inc, West Columbia, SC) to prepare an 11% 
solution. This solution was pumped at 29 µL/min through a 22 gauge needle at 7 kV (+) and 
collected on an aluminum plate at 7 kV (-) and 20 cm away. The first layer of PDO fibers was 
deposited to an aluminum collector by vertically electrospinning 350 µL of the solution (Figure 
29D-i). The printed PVA template was placed on the PDO fibers (Figure 29D-ii) before 
electrospinning a second layer of 350 µL PDO (Figure 29D-iii). The scaffold was removed from 
the aluminum collector and washed twice in deionized water with agitation for 24 h to remove 
PVA (Figure 29D-iv). 
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Figure 29. Fabrication of microvascular (MV) templates and electrospun MV scaffoldsFabrication of 
microvascular (MV) templates (a-c) and electrospun MV scaffolds (d-e) by FDM and electrospinning respectively.  
a) FDM extrudes a filament through a small (0.35mm) nozzle to fuse the material to the underlying layer. b) 
Automation of FDM process allows many templates to be quickly and uniformly produced. Supporting branches 
shown connecting the inlet and outlet are printed as part of the continuous path and trimmed before use. c) 
Optimization of the printing path and extrusion parameters permit fabrication of small diameter branched structures. 
d) Cross-sectional view of MV scaffold fabrication using templated electrospinning. e-f) Completed MV scaffolds 
with 2 (e) and 4 (f) bifurcations. 
 
Scaffold Characterization 
Scanning electron microscopy. The morphology of microchannels in electrospun PDO 
scaffolds was examined by scanning electron microscopy (SEM). Samples were fixed with 2.5% 
glutaraldehyde and dehydrated with graded ethanol and hexamethyldisilazane (HMDS). 
Dehydrated samples were sputter-coated with 3.5 nm gold and images were taken at 3 kV 
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acceleration voltage with a field emission SEM (JSM-6330F, Jeol, Tokyo, Japan). Average 
diameter of fibers was measured using ImageJ software (NIH, Bethesda, MD). 
 
Figure 30. Scanning electron micrographs of electrospun PDO scaffoldswith PVA template in place (a/d) 
and after template is dissolved (b/e).  HUVECs attached to fibrous PDO with a sprawled morphology (c/f).  Scale 
bar: a-c (100 µm), d,e (40 µm), f (20 µm) 
 
Mechanical Testing. Electrospun PDO sheets were punched using a dogbone-shaped die 
(28.75 x 4.75 mm outer dimensions, 8.25 x 1.5 mm narrow region). The thickness of hydrated 
samples was measured with a dial caliper (Mitutoyo).  Uniaxial tensile tests were performed to 
failure at 25 mm/s using a 50 N load cell on a MTS Insight (Eden Prairie, MN). Suture retention 
strength was measured by methods described previously.244 Briefly, a 6-0 suture was inserted 2 
mm from the end of square sample and pulled until rupture. Suture retention strength was 
calculated as load/(suture diameter × sample thickness).   
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Figure 31. Mechanical properties of electrospun PDO sheetsMechanical properties of electrospun PDO 
sheets.  a) Uniaxial tensile strength (UTS).  b) Suture retention strength (SRS). 
 
Cell Attachment in Static Culture 
HUVECs (Lonza, Walkersville, MD) were cultured on fibronectin-coated (1 μg/cm2; 
Chemicon International, Temecula, CA) plates using endothelial basal medium-2 (Lonza) 
supplemented with 10% fetal bovine serum (Hyclone, Logan, UT), 1% L-glutamine-penicillin-
streptomycin (Mediatech, Manassas, VA), and endothelial growth medium-2 SingleQuot Kit 
(Lonza). Fibrous PDO sheets were cut to circular samples 12 mm in diameter and placed under 
metal rings (inner diameter 7.5 mm) in 24-well plates. They were sterilized with 70% ethanol, 
rinsed with PBS, and incubated with culture medium at 37 °C for 24 h.  HUVECs (passage 4) 
were seeded at 1.0 × 106 cells/mL and cultured for 1 day under static conditions.   
Bioreactor Culture 
Exel PTFE safelet I.V. catheters (Fisher Scientific, Pittsburgh, PA) were inserted into the 
inlet and outlet channels and secured by PTFE sealant tape to provide connections for the 
bioreactor tubing. The fibrous PDO scaffold was transferred into a bioreactor chamber made 
with polycarbonate sheets (thickness 2.4 mm) and a silicone rubber (thickness 3.1 mm).  
HUVECs were seeded in the lumen of the scaffold at 1.0 × 106 cells/mL and allowed to attach 
uniformly to the scaffold lumen by rotating the chamber as 2 rpm for 4 h. After rotation, the 
bioreactor chamber was attached to the perfusion setup and the scaffolds were perfused with 
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fresh medium by using a peristaltic pump as a rate of 0.6 ml/min for 10 days. Medium was 
changed at every other day. 
Fibrous PDO scaffolds were harvested on day 10 and washed with PBS. Both inlet and 
outlet channels were cut from scaffolds, embedded in Tissue-Tek optimal cutting temperature 
compound (Sakura Finetek Inc., Torrance, CA) and snap-frozen in liquid nitrogen.  Cryosections 
were used for immunofluorescence staining to examine HUVEC lining and cell-cell junction.  
Immunofluorescence staining 
Cryosections 8-μm thick (for cross-sectional view) and other scaffolds regions (for top-
down view) were fixed in 4% paraformaldehyde for 10 min at room temperature and rinsed 
twice with PBS. Tissue sites of each slide were blocked with 5% normal goat serum (Sigma) for 
1 h at 37 °C, incubated with primary antibodies in 1% goat serum for 45 min at 37 °C, and 
incubated with secondary antibodies in 1% goat serum for 45 min at 37 °C. For HUVEC 
staining, rabbit polyclonal anti-human CD31 (1:100; Santa Cruz Biotechnology, Dallas, TX) and 
von Willibrand factor (vWF) (1:200; Abcam, Cambridge, MA) were used as primary antibodies 
and Alexa Fluor 594 goat anti-mouse IgG (1∶ 400; Invitrogen) and secondary antibody. For 
visualization of cell-to-cell junctions, rabbit polyclonal anti-human VE-cadherin (1:100; Santa 
Cruz) and Alexa Fluor 488 goat anti-rabbit IgG (1:200; Invitrogen) were used as primary and 
secondary antibodies. Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI; 
Invitrogen). Fluorescent images were viewed and captured with an inverted microscope (Eclipse 
Ti-E; Nikon Instruments, Melville, NY). 
Perfusion 
The bioreactor chamber was detached from the perfusion setup on day 10 and culture 
medium was aspirated from the lumen of microvascular channels of fibrous PDO scaffolds. 
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Fluorescein isothiocyanate (FITC)-labeled dextran (150 kDa, Sigma) solution was prepared in 
PBS (20 mg/mL) and injected into the lumen to visualize perfused microvascular channels 
through endothelial cell barrier. Fluorescent images were captured on an inverted microscope. 
The intensity of fluorescence in perfused microvascular channels was measured using the NIS-
Elements software (Nikon).  Acellular PDO scaffolds were used as a negative control.   
 
Figure 32. In vitro endothelialization of fibrous microvascular scaffolds.a) CD31/VE-cadherin staining of 
microvessel after 10 days culture (top-view). Asterisk indicates area of low cell density (Scale: 150 µm) b) 
DAPI/vWF staining of cross-sections of inlet/outlet sections after 10 days of culture (Scale: 100 µm) c) Perfusion of 
acellular and 10-day cultured scaffolds with FITC-labelled dextran.  Channels after 10 days of culture demonstrate 
reduced permeability.  The presence of FITC-labelled dextran beyond the channel walls indicates that channels are 
not yet water-tight.  Pixel intensity along horizontal line is shown in graph (Scale: 1 mm) 
4.1.3 Results and Discussion  
Combining FDM with Templated Electrospinning 
We present a micropatterning technique that combines FDM with the method of templated 
electrospinning (Figure 29).245   FDM is an inexpensive SFF platform that offers high versatility 
for the manufacture of templates, allowing us to print branched patterns that mimic vascular 
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networks.  While SFF and electrospinning have been used in various combinations for other 
applications,80, 96, 98, 99, 246-249 the final composites contain material from both sources.  In 
contrast, we used FDM only as an indirect fabrication method to create sacrificial templates used 
to pattern the electrospun meshes.   
Since the FDM templates are non-linear patterns, they cannot be removed manually as 
previously described.245  Instead, we fabricated templates out of PVA removed safely by 
dissolving in water.  PVA is nontoxic, noncarcinogenic, generally regarded as safe by the 
USFDA and has been used in tissue adhesion barriers, nerve guides, and cartilage 
replacement.250  FDM also offers a high-throughput  (Figure 29B) alternative to the previous 
labor-intensive and time-consuming templating methods.245  With FDM, template designs can be 
easily modified or scaled within the software. 
The production of intricate single-layer templates differs significantly from the large 3D 
structures FDM is intended to produce.  This presents several challenges to using FDM for our 
application.  Those familiar with FDM recognize that the first layer is most likely to cause errors 
with adhesion to the print bed and layer thickness.  By using a continuous path and optimized 
printing conditions (e.g., nozzle temperature, bed temperature, level bed, and dry filament), we 
demonstrate uniform dimensions and reproducible deposition (Figure 29C).  Additionally, blue 
painter tape (3M ScotchBlue 2090) was applied to the bed to improve PVA adhesion.  Another 
drawback of FDM is the high heat (210oC) needed to extrude PVA.  Since this heat also melts 
common degradable polyesters including PDO, the templates were transferred from the print bed 
rather than directly printed on the electrospun fibers.   
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Benefits of Microvascular Electrospun Scaffolds 
Both the fibrous structure and the material properties of PDO contribute to the porous, 
suturable, and biodegradable nature of these scaffolds.  Electrospun PDO produced well-defined 
microfibers with 1.5 µm average diameter (Figure 30F) with highly interconnected interstices to 
permit rapid diffusion of small molecules.  Electrospun fibers also provide mechanical benefits 
compared to porous scaffolds produced by other methods such as solvent casting particulate 
leaching.251  Mechanical testing demonstrates that fibrous PDO scaffolds are strong (9.6 MPa) 
with suture retention strength of 142 N/mm2 (Figure 31).  This is close to commonly-sutured 
electrospun poly(caprolactone) (PCL) (164 N/mm2) and several times greater than poly(ether 
urethane urea) (PEUU)/ECM blends (35-59 N/mm2) which were sutured for in vivo fixation.244, 
252  PDO is a FDA-approved material used for sutures that resorb within 6 months or faster for 
fibers with high surface area. 242, 243, 253  In vitro culture of HUVECs on electrospun PDO fibers 
also demonstrate good attachment as indicated by the sprawled morphology (Figure 30C&F).   
Microvascular Endothelialization 
Electrospun fibers are typically packed too tightly to permit rapid cell infiltration.254  To 
facilitate endothelialization of our scaffolds, we introduced microvascular networks by templated 
electrospinning.  Fibrous PDO layers deposit tightly around the PVA template (Figure 30A&D) 
and retain the channel shape even after PVA is dissolved (Figure 30B&E).  This process 
transfers the microvascular pattern to the fibrous scaffold (Figure 29E). Figure 32 demonstrates 
that these channels permit cells to be seeded into predetermined regions of the scaffold.  The 
fibrous nature permits fluid extravasation while seeding the cells through a filter-like process: 
fluid from the injected cell suspension exited through the fibers while trapping the cells against 
the channel walls.   
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After culturing for 10 days in a bioreactor, HUVECs attached and proliferated on the 
PDO fibers and formed a near-confluent layer. The cells formed adherens junctions along the 
channel as demonstrated by VE-cadherin and CD31 staining (top-view) (Figure 32A). The 
presence of HUVECs in the scaffold was further revealed by von Willibrand factor (vWF) 
staining of the channel cross-sections (Figure 32B). HUVEC staining within microvascular 
scaffolds revealed that despite being porous, the fibers prevent cells from immediate escape from 
the microchannels.  Maturation of the HUVECs and confluence of EC layer were further 
evaluated by visualizing flow of FITC-labeled dextran solution perfused into the lumen (Figure 
32C).  The cultured microvessels show a drastic reduction in leakiness compared to the unseeded 
scaffold, representing barrier function of EC layer.  Since some leaking still occurs, longer 
culture time may be necessary to allow HUVEC coverage of areas with low cell density (Figure 
32A asterisk).  Additionally, we expect to stabilize HUVECs to form water-tight vessels by 
coculturing with mural cells such as pericytes.255   
We produced channels approximately 500 µm in diameter which is similar to small 
arteries and venules and will provide intrinsic vascularization to the most of the tissue.256  By 
using a highly porous and degradable scaffold, we anticipate that further branching of the 
smallest vessels will be rapidly obtained by angiogenesis.  Although FDM can achieve feature 
sizes of 250 µm, finer resolution is difficult to achieve since reducing nozzle diameter rapidly 
increases the extrusion pressure as described by the Hagen-Poiseuille equation.63, 92  Thus, future 
work we will pursue other precise technologies such as pressure assisted microsyringe (PAM) 
and electrohydrodynamic (EHD) jet (direct melt electrospinning) which are capable of 10-30 µm 
feature size.63, 92, 257  Additionally, we recognize the non-circular shape of the vessels that results 
from the square template cross-sections in combination with the fiber deposition pattern.  As 
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template height increases, electrospun fibers encapsulate the template less tightly,246 resulting in 
the sloped sides observed in Figure 32B.  Due to this height effect, future iterations will use short 
and wide templates in conjunction with elastomeric fibers (e.g., poly(glycerol sebacate) (PGS)) 
to produce circular shapes once exposed to blood pressure, similar to balloon inflation.   
4.1.4 Summary 
In summary, we present a new technique that uses FDM with water-soluble PVA as an indirect 
fabrication method to pattern microvascular networks within fibrous 2D structures which we 
anticipate rolling258 or layering98 into 3D scaffolds.  This approach overcomes several significant 
challenges of engineered microvasculature including limited perfusion capacity, low strength 
associated with hydrogel approaches, and nondegradability for PDMS-based approaches.  We 
expect that the thin (<100 µm) fibrous channel walls will improve perfusion of parenchymal 
cells.  The effectiveness of this device at perfusing the parenchyme will be tested by coculture 
experiments before in vivo validation.  
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5.0  ELECTROSPUN POLY(GLYCEROL SEBACATE) (PGS) 
Chapter Aim 
Pilot studies with implanted (PCL-PLGA) nerve guides suggest that a faster-degrading material 
that induces a milder inflammatory response would improve nerve regeneration.  Additionally, 
we observed some delamination of PDO microvascular scaffolds.  We hypothesized that the 
rapid degradation of poly(glycerol sebacate) (PGS) and the cohesive properties of oligo(glycerol 
sebacate) (OGS) could be used to address these limitations.  Additionally, the mechanical 
modulus of PGS is suitable for matching that of nerve and blood vessel. The aim of this chapter 
was to create fibrous PGS by developing an electrospinning protocol that does not alter the PGS 
properties. PGS was electrospun by blending prepolymer (OGS) with poly(vinyl alcohol) (PVA) 
followed by thermal crosslinked.  We report a method of electrospinning PGS that yields strong 
constructs with no observable changes to modulus or cytocompatibility. 
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5.1 ELECTROSPUN POLY(GLYCEROL SEBACATE) FOR IMPROVED 
MECHANICAL PROPERTIES 
5.1.1  Introduction  
Scaffold mechanical properties play an important role in the cellular microenvironment, 
influencing cell motility, organization, and differentiation.17, 18  Traditional plastic biomaterials 
(poly(caprolactone) (PCL), poly(glycolic acid) (PGA), poly(lactic acid) (PLA));259 as well as 
elastomeric biomaterials (poly(ether urethane urea) (PEUU), poly(3-hydroxybutyrate-co-4-
hydroxybutyrate) (P3HB-co-P4HB), and poly(caprolactone-co-lactic acid) (PCL-co-LA));260 
have moduli in the MPa-GPa range, resulting in mechanical mismatch with soft tissue (kPa 
range).  Poly(glycerol sebacate) (PGS) is a soft elastomer with a modulus between 25-1200 kPa 
depending on crosslinking density.261  This has made PGS a unique and desirable material for 
soft tissue applications including vascular grafts,192 cardiac patches,262 nerve regeneration,160 and 
retina repair.263  Additionally, PGS degrades rapidly in vivo into the metabolites glycerol and 
sebacic acid, minimizing the duration of the host’s inflammatory response.261, 264  
The adoption of PGS scaffolds have been hampered by their need for gentle handling. 
The low tensile strength of scaffolds produced by solvent casting porogen leaching 265 precludes 
their use in load bearing environments or implants requiring suture anchoring. Porogen leached 
PGS can be composited with a stronger material to improve surgical handling,192 but the 
additional material will influence the mechanical behavior and degradation of the scaffold.  
Constructing fibrous scaffolds by electrospinning can improve the strength of PGS 
scaffolds251 while introducing a fibrous topography resembling the structure of extracellular 
matrix.241  However, electrospinning thermosets like PGS is challenging266 for two reasons: (1) 
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The insolubility of crosslinked PGS in organic solvents necessitates the use of the 
noncrosslinked precursor, PGS prepolymer or oligo(glycerol sebacate) (OGS); and (2) OGS has 
a glass transition temperature (Tg) below room temperature causing the polymer to flow and 
fibers fuse into a nonporous sheet. This fusion is exacerbated by the heating needed for thermal 
crosslinking.   
To overcome these challenges, we and others have developed a range of methods to 
electrospin PGS (Table 1).  All of these techniques blend OGS with a carrier polymer that 
readily forms fibers to facilitate fiber formation. Unfortunately, if the carrier polymer is not 
removed or if OGS is not crosslinked, the mechanical properties differ substantially from those 
of unaltered PGS 264.  Our objective was to develop a simple and inexpensive method for 
electrospinning PGS scaffolds that retains the mechanical properties of crosslinked PGS without 
using toxic crosslinkers. Resultant scaffolds show improved suture retention and ultimate tensile 
strength compared to porogen leached scaffolds, suggesting an advantage in handling. 
5.1.2  Experimental Section 
Materials 
Poly(vinyl alcohol) (PVA) was generously provided by Soarus LLC (Arlington Heights, 
IL) and 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) was purchased from Oakwood Products Inc. 
(West Columbia, SC).  PGS prepolymer (OGS) was synthesized in house as previously 
described.264   
Production of fibrous PGS sheets 
Fibrous PGS sheets were fabricated by 1) electrospinning OGS-PVA blends, 2) thermal 
crosslinking, and 3) purifying with water and ethanol as outlined in Figure 33. 
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Figure 33. Fabrication of fibrous PGS sheets1. Electrospin OGS-PVA onto rotating (100 RPM) mandrel 30 
cm from dispensing syringe needle at (+9kV), and 30 cm from negatively-charged needle (-9kV).  2.  Crosslink the 
sheet with high temperate and vacuum.  3. Purify samples by washing in water for 24h to remove soluble PVA.  
Rinse in graded ethanol dilutions to remove non-crosslinked OGS. 
 
A 16 w/v% solution was prepared by mixing OGS and PVA at 55:45 mass ratio and 
dissolving in HFIP overnight.  This solution was pumped at 29 µL/min through a 22 gauge 
needle serving as the spinneret. Positive and negative 9 kV were applied to the spinneret and 
another needle positioned 60cm from the spinneret, respectively.  Electrospun fibers were 
collected on a rotating aluminum mandrel (100RPM) placed between the needles at a 30 cm 
distance from the spinneret to (Figure 33-1). No voltage was placed on the mandrel. 
Fibrous sheets were removed from the collector and crosslinked in a preheated vacuum 
oven under high temperature (120oC-150oC) and vacuum (-700mm Hg) (Figure 33-2). We 
investigated four crosslinking times at 120oC: 24, 48, 72, and 96h. Crosslinking at high 
temperature was also performed (120oC-24h followed by 150oC-24h).   
Crosslinked fibrous sheets were purified by water and ethanol washes (Figure 33-3).  
PVA was removed by washing three times in ultrapure, deionized water (diH2O) with gentle 
agitation for 24h.  Non-crosslinked OGS was removed via serial ethanol washes (100%-1h, 70%-
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1h, 50%-15min, 25%-15min, diH2O-15min three times) with gentle agitation. Hydrated samples 
were used immediately or lyophilized for storage.   
Characterization of electrospun PGS sheets 
Fiber morphology was evaluated by scanning electron microscopy (SEM).  Samples were 
prepared for SEM by adhering onto aluminum stubs with conductive carbon tape before sputter 
coating with gold-palladium to a 3.5nm thickness and viewing on a JSM-6330F SEM (JEOL, 
Tokyo, Japan).  Fiber diameter was measured by image analysis with ImageJ (NIH, Bethesda, 
MD).   
Purification was evaluated by mass loss.  Dry samples were weighed on a microbalance 
before undergoing washing protocols.  Sample thicknesses were also measured with dial calipers 
before and after purification.  Fourier transform infrared attenuated total reflectance (ATR-FTIR) 
was measured on a Nicolet iS10 FTIR spectrometer (Thermo Scientific, Waltham, MA) after 1) 
electrospinning, 2) crosslinking, and 3) purification.  Samples were compared to control films of 
pure PGS at the same crosslinking conditions.  The thermal properties for the same groups were 
also measured by differential scanning calorimetry (DSC).  Samples underwent two cycles of 
heating to 200oC and cooling to -80oC at 20oC/min. 
Mechanical properties 
Mechanical properties of electrospun PGS blends were measured by uniaxial tensile 
testing.  Samples were cut into dog bone shaped pieces using a customized punch with outer 
dimensions (28.75mm (L) * 4.75mm (W)) and a narrow region (8.25mm (L) * 1.5mm (W)).  
Sample thickness was measured by dial calipers.  Samples were placed in an Insight MTS (Eden 
Prairie, MN) and then hydrated before straining to failure at 25 mm/min.    Multi-cycle testing 
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from 10 to 100% strain for 100 cycles at 100 mm/min was performed to evaluate elastic 
recovery.  Samples were kept hydrated during this process.   
Suture retention strength (SRS) was measured by inserting a 4-0 suture 2mm from the 
edge of the long axis of 5mm x 20mm samples and strained to rupture.  Suture retention strength 
was calculated as maximum load/(suture diameter x sample thickness) in N/mm2. 
Cell attachment and viability 
Purified and unpurified samples of electrospun PGS sheets crosslinked at 120oC-48h and 
120oC-24h, 150oC-24h were autoclaved at 121oC for 27min.  Fiber morphology of autoclaved 
PGS sheets was observed via SEM (Figure 34). 
Washed PGS sheets (1.2cm diameter) were placed under metal rings placed in 12-well 
plates and incubated in media (DMEM + 10% FBS +1% antibiotic) for 24h.  3T3 fibroblasts 
were seeded at 10,000 cells per well and cultured for 24h. Cell viability was assessed by 
Live/Dead assay (Molecular Probes, Eugene, OR) using fluorescent imaging.  Replicates were 
fixed in 2.5% glutaraldehyde before dehydrating with a series of ethanol, followed by 
hexamethyldisilazane (HMDS, Alfa Aesar, Ward Hill, MA). Cell attachment was examined by 
SEM. 
Cytocompatibility was performed according to the ISO 10993-5 standard for extract tests.  
Autoclaved disks were incubated in media at 20 g/mL overnight at 37oC.  3T3 fibroblasts were 
plated in a 96-well plate at 10,000 cells per well for 3h before incubating with the extract at 1 
and 10mg/mL for 24h.  Cells were incubated with serum-free medium with 2uM calcein AM and 
4 uM ethidium homodimer for one half hour before capturing FITC and TRITC images at the 
center of each well (n=3 for each sample) with Nikon Eclipse Ti microscope.  Live and dead cell 
numbers were quantified using "object count” in Nikon Elements software to threshold images 
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and exclude objects less than 10µm.  Live percent was calculated as the number of live cells/total 
cells x 100.  Since all wells contained some dead cells, the live percent was normalized to 
controls grown on tissue culture polystyrene (TCPS) with no extract. 
Electrospun constructs 
Tubular scaffolds were fabricated by electrospinning around various-sized mandrels 
coated with 1-2 w/v % hyaluronic acid and crosslinking and purifying as described above.  
Multi-laminate constructs were constructed by stacking fibrous sheets of electrospun OGS-PVA 
and placed between Teflon blocks while crosslinking to prevent curling.  PGS arteriovenous 
(AV) shunt grafts were constructed by combining the tubular scaffolds with templated patterns 
as described in Aim 2.  
Statistical analysis 
ANOVA was performed in Minitab using the general linear model.  Post-hoc 
comparisons with the control were performed using Bonferroni correction and 95% confidence 
interval. 
5.1.3 Results and Discussion 
Review of prior work 
OGS is intrinsically difficult to electrospin.266, 267  Existing literature pertaining to 
electrospun OGS uses a carrier polymer that is blended or electrospun by coaxial set-up (Table 
1).  Using PCL as a carrier polymer prohibits thermal crosslinking the PGS since PCL has a low 
melting point, resulting in uncrosslinked OGS-PCL blends in which PCL dominates the 
mechanical properties.268  Additionally, noncrosslinked OGS may have a cytotoxic effect if not 
removed from the scaffold.269  Gelatin has been used as a carrier but it requires crosslinking 
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agents such as glutaraldehyde, acrylate-ultraviolet (UV), or 1-Ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC)-N-hydroxysuccinimide (NHS), which may adversely impact 
biocompatibility.270-272  Coaxial electrospun OGS-PLLA tolerated thermal crosslinking and 
removal of the PLLA sheath by dissolution in dichloromethane (DCM).267  However, DCM is 
toxic and a suspect carcinogen, requiring stringent and complete removal before biomedical 
applications.  Our group has experienced similar challenges using a range of other carrier 
polymers (Table 1).  PCL and PLGA carrier polymers melted during heating, poly(dioxanone) 
(PDO) and gelatin blends were severely weakened by heat, and poly(ethylene terephthalate) 
(PET) required purification using large quantities of toxic HFIP to remove the carrier polymer. 
Table 1. Review of PGS electrospinning. Cells highlighted in blue meet our criteria of standard 
electrospinning, thermal crosslinking, and removal of carrier polymer.  Cells highlighted in green match mechanical 
property with that of previously reported thermal-crosslinked PGS.  *Mechanical testing performed at dry state. 
Carrier Polymer 
i. 
Electrospin 
Method 
ii. 
Crosslink  
method 
iii. 
Carrier  
removal 
UTS  
(MPa) 
Strain (%) 
Modulus  
(MPa) 
PGS electrospinning in literature 
PLLA (2008) 267 Core-sheath Thermal DCM - - - 
PLLA (2013) 273 Core-sheath Thermal X 0.6-1.2 25 12 
PCL (2013) 274 Standard X X 3.5 - 7 
PCL (2010) 268 Standard X X 1.7-2.5 400-500 9-35 
Gelatin (2009) 270 Standard Acrylate-UV X 0.05 30-40 0.1 to 1 
Gelatin (2011) 271 Core-sheath Glutaraldehyde X 2* 61* 6* 
Gelatin (2013) 275 Standard EDC-NHS X 0.3-1 182-229 0.14-0.36 
Development of PGS electrospinning within our laboratory 
PCL Standard X X 
 
PLGA Standard Isocyanate THF 
PDO Standard Thermal X 
Gelatin Standard Thermal X 
PET Standard Thermal HFIP 
PVA Standard Thermal H2O 0.8-1.3 200-800 0.1-0.8 
PGS 
PGS Film (Thermal-crosslinked)261 >0.5 >330 0.025–1.2  
 
We ultimately selected PVA for the carrier polymer because (1) it does not melt during 
thermal crosslinking, and (2) it is highly water-soluble, enabling simple removal by dissolution 
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in water.  Additionally, PVA itself is a nontoxic and noncarcinogenic biomaterial. It is approved 
by the FDA for applications in food chemistry and pharmaceuticals,276 and is also being 
investigated for use in contact lenses, wound dressing, coatings for sutures and catheters, and 
other tissue engineered scaffolds.276, 277  We acknowledge that some PVA appears to be 
incorporated into the final fibers.  However, our results suggest that PVA does not significantly 
change the modulus or cytocompatibility compared to PGS alone.   
Fiber morphology 
Blending OGS with PVA enabled us to fabricate homogeneous round fibers of 2.8 ± 
1.2µm diameter (Figure 34A) with fusion restricted to the contact points between fibers (Figure 
34B).  Although alignment was not the focus of this work, collection around a rotating mandrel 
resulted in elongated fibers oriented along the circumferential axis.  We anticipate that fiber 
alignment can be further controlled by rotation rate, disk collectors, or auxiliary electrodes as 
previously described.278  Randomly-deposited fibers were also electrospun onto a stationary plate 
(not shown), but were not characterized due to strong adhesion to the plate. 
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Figure 34. SEM of PGS-PVA fibers after electrospinning, crosslinking and purification.(a-b) Electrospun 
OGS-PVA fibers. (c-e) PGS-PVA after crosslinking at respective conditions.  (f-h) PGS-PVA fibers after washing in 
water for 24h.  (i-k) PGS-PVA after ethanol purification.  (l-n) High magnification images of fiber structures from i-
k respectively. (*) indicates respective sample after autoclaving. (Scale bar: 10µm for a, c-k and *; 2µm for l-n) 
 
Maintaining the defined fibrous structure during thermal crosslinking was challenging 
since elevated temperatures cause OGS-PVA to soften and fuse. To improve fiber quality and 
minimize fiber fusion, we tested three different OGS-PVA mass ratios (60:40, 55:45, 50:50) and 
two different crosslinking conditions (instantaneous or gradual (4oC/h) heating) Results indicate 
that a ratio of 55:45 OGS:PVA is optimal for fiber quality (Figure A1), and that ramped heating 
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does not reduce fusion.  The fibrous structure is retained after crosslinking but demonstrates 
increased fusion with more heat (Figure 34C-E).   
We assessed the effects of water and ethanol purification on fiber morphology. Water 
washing appears to have little effect on fiber morphology (Figure 34F-H) while ethanol washes 
alter fiber shape and/or surface topography depending on crosslinking conditions (Figure 34I-K).  
Purified 120oC-24h fibers are irregularly-shaped and have small spines branching off the fiber 
surface (Figure 34L).  Purified 120oC-48h fibers exhibit a semi-tubular shape with a hollow core 
(Figure 34M).  PGS-PVA fibers crosslinked 120oC-24h, 150oC-24h are round but with a porous 
nanostructure and some recession near the fusion points (Figure 34N).  We believe that the non-
uniform fiber cross-section arises due to formation of OGS-rich and PVA-rich domains may 
result from OGS pooling near the bottom of fibers due to gravity; OGS flows at 120oC and 
150oC, so it some OGS may pool at the bottom the OGS-PVA blended fiber prior to forming 
cross-linked PGS. 
While the processing of thermosets is difficult, their resistance to heat and solvent is 
beneficial for sterilization.  Many common degradable polyesters (PCL, PLGA, and PDO) have 
low melting points and cannot be autoclave sterilized.  We demonstrate that purified PGS can be 
autoclaved without loss of the fibrous structure (Figure 34*).  The presence of a significant 
amount of OGS in the unpurified low heat sample (Figure 34 D*) caused fusion between gaps 
when heated in the autoclave.  In contrast, the purified sample (Figure 34 J*) containing only 
PGS retained its fibrous structure. 
Purification Analysis 
The remaining mass of all samples after water washing was greater than 55%, the 
percentage of OGS in the original solution (Figure 35A).  This indicates that water washing is 
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not sufficient to remove all PVA.  After ethanol washing, 120oC-24h and 120oC-48h were the 
only groups with less than 55% mass remaining (Figure 35A).  Mass loss during the water wash 
likely represents PVA removal due to its high solubility in water.  Mass loss during the ethanol 
wash likely includes OGS and PVA that was physically entangled within it, since both OGS and 
PVA are soluble in ethanol.  These results suggest that the three most crosslinked groups (120oC 
-72h, 120oC-96h, 120oC -24h/150oC -24h) have some residual PVA in the final product.  It is 
also possible that some residual PVA remains in the other groups since we predict substantial 
OGS mass loss in the ethanol wash (Figure A2). 
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Figure 35. Purification analysis.(a) Percent of unwashed mass and thickness remaining after water and 
ethanol washes. (b) ATR-FTIR spectra of PVA, PGS and PGS-PVA during purification. (c) Heating and cooling 
curves from DSC measurements.  Colors use the same legend as (b). 
 
Quantification of residual PVA in the final product is difficult due to the chemical 
similarity to PGS.  FTIR spectra of noncrosslinked OGS-PVA fibers show characteristics of both 
PVA (broad alcohol peak at 3300-3500 cm-1) and OGS (alcohol peak at 3500 cm-1, alkane at 
2800-3000, carbonyl at 1750 and 1700, and carbon-oxygen bond at 1000-1300 cm-1) (Figure 
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35B).   FTIR spectra for PGS-PVA fibers and PGS films are similar except for the broad alcohol 
peak remaining in the fibrous sample.  In the washed 120oC-24h fibers (cyan line) and less 
noticeably in the washed 120oC-24h, 150oC-24h group (pink line), the alcohol peak is shifted to 
higher wavenumber closer to that of the washed PGS film.  Differential Scanning Calorimetry 
(DSC) was also performed to further elucidate the PVA content (Figure 35C).  PVA has a 
melting point of 165oC that appears in both PGS-PVA samples regardless of purification.  The 
PVA crystallization temperature of 135oC also appears in most PGS-PVA samples but is more 
subtle than the melting peaks.  The most likely scenario for this residual PVA to occur is via 
physical entanglement within PGS fibers.  Other possibilities involve PVA simply becoming 
insoluble as a result of thermal treatment277 or chemically crosslinking with PGS by 
condensation reactions.   
Successful removal of OGS during purification washes is also important.  In the FTIR 
spectrum, the OGS peak around 1700cm-1 279  significantly narrows after washing. DSC shows a 
melting point of 10oC for OGS that shifted down to around -10oC as crosslinked to PGS.280  
PGS-PVA fibers for both crosslinking groups demonstrated this crosslinking-dependent shift of 
the Tm(PGS).  Additionally, the multi-peak Tm(PGS) profile of the purified samples closely 
matches that of the PGS film controls.  The images of autoclaved fibers also provide insight into 
the OGS removal.  The fibers in Figure 34D* are fused due to the significant OGS remaining, 
which is fluid enough to fill in pores during autoclaving.  This effect disappears in Figure 34J* 
since the OGS is removed by the ethanol wash.  Furthermore, autoclaved samples of both high 
heat crosslinked samples (Figure 34 E* and K*) shows little change, indicating that most of the 
OGS has been crosslinked to thermal-resistant PGS. 
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Mechanical properties  
Uniaxial tensile testing was performed to evaluate the effect of three different 
crosslinking regimens on tensile properties (Figure 36).  Samples were strained perpendicular 
and parallel to the electrospinning mandrel axis, although the orientation exhibited little effect on 
results.  All samples demonstrated approximately 1 MPa of ultimate tensile strength (UTS) 
regardless of crosslinking.  As crosslinking increased, the modulus increased from 100 to 800 
kPa while the strain to failure (STF) decreased from 800% to 200% (Figure 36A).   Elasticity 
was measured by performing 100-cycle multi-cycle testing.  The highest crosslinking group 
exhibited some plastic deformation while both lower crosslinking groups showed full recovery 
after 100 cycles to 100% strain (Figure 36C).  Similarly, the highest crosslinking group seemed 
more brittle, resulting in the lowest suture retention strength (SRS) (Figure 36D).   
 
Figure 36. Mechanical testing(a) Tensile testing plot of samples strained parallel (||) or perpendicular (⊥ ) 
to fiber axis.  (b) Comparison of fibrous PGS to previously reported mechanical properties for porous and non-
porous films under similar conditions. Note: UTS values for nonporous and porous films was during testing of dry 
samples.  “Med” crosslinking was 120oC for all samples. “High” crosslinking for porous and nonporous films was 
150oC-48h but 120oC-24h, 150oC-24h for fibers. (c) Multi-cycle testing of high and low heat-crosslinked samples, 
strained to 10-100% for 100 cycles. (cycle 1:dotted lines, cycle 100: solid lines) (d) Suture retention strength. 
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PGS is a desirable material for soft tissue replacement because of modulus in the kPa 
range similar to those tissues.  Despite the possible presence of residual PVA, our fibrous PGS 
sheets exhibited similar moduli to reported values for porous PGS (Figure 36B)265 while 
demonstrating 3 times greater strength and 3 to 8 times larger strain-to-failure.  As a biorubber, 
PGS can be elongated substantially and is elastic during cyclic testing.  The increased elongation 
observed for electrospun PGS sheets is likely due to the ability of fibers to reorient during 
loading.  Furthermore, we demonstrate that mechanical properties can still be tuned by adjusting 
the degree of crosslinking.  Most importantly, we believe that this is the first report of suturable 
PGS scaffolds.  The inability to hold suture was a significant shortcoming of SCPL PGS 
scaffolds and a leading motivation for this work.   While the value for suture retention strength is 
less than PEUU blends (35-59 N/mm2),244 the large strain to failure for 120oC-24h and 120oC-
48h samples (Figure 36D) allows the scaffold to be stretched while suturing  in contrast to 
tearing as observed for PGS-gelatin samples (Figure A3).  
This elastomeric response distinguishes our electrospun PGS scaffolds from those 
produced in other reports. Electrospun OGS or PGS blended with polyesters results in stiff 
materials due to the continued presence of the carrier.  No mechanical data was reported for PGS 
fibers after PLLA removal in coaxially spun PGS-core PLLA-sheath fibers, but with PLLA still 
present elongation is one tenth that of PGS and the construct is 300 times stiffer.273  Mechanical 
properties of PCL-OGS blends were closer to that of PCL alone than PGS elastomer.268  PGS-
gelatin blends closely match PGS properties when hydrated, but are more stiff by several orders 
of magnitude when dried and demonstrated rapid propagation of tear defects caused by suturing 
(Figure A3).   
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Cytocompatibility 
We believe that the purified product has similar cytocompatibility to previously reported 
thermally-crosslinked PGS since no crosslinking agents were added.  Additionally, since PGS 
was crosslinked, the scaffolds were washed in ethanol to remove residual monomers and 
unreacted OGS, believed to harm cells if not removed.262, 269  Furthermore, the wash steps are 
performed in water and ethanol, avoiding harsh organic solvents.  Live/Dead staining for cells in 
direct contact with the PGS sheets demonstrates the presence of live cells (Figure 37B).  
However, due to the red autofluorescence of the fibers, dead cells could not be clearly observed. 
Cytotoxicity of extracts from fibers was assessed using three crosslinking conditions and two 
concentrations for both purified and unpurified samples.  Results were quantified by Live/Dead 
staining.  None of the purified samples exhibited any significant difference in cytotoxicity from 
solvent casted PGS films, suggesting that residual PVA has a minimal effect.   Only the non-
purified 120oC-24h group at 10mg/mL demonstrated significantly reduced cell viability 
compared to the control.  As previously reported, the least crosslinked group has the most 
residual monomer and greatest effect on cell viability.262, 269  However, this effect disappears if 
the fibers are washed with water and ethanol, suggesting that the purification steps are sufficient 
for removing this initial cytotoxicity.  In agreement with previous observations, cells attach to 
PGS sheets264 with morphology that changes from round to elongated as substrate stiffness is 
increased (Figure 37C).281, 282  Further evaluation of cell response will be evaluated in vivo.   
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Figure 37. 3T3 fibroblast cytocompatibility with PGS-PVA fibers.(a) Normalized viability of 3T3 cells 
cultured with extract from PGS-PVA samples “+” and “-“ indicate with or without purification in water and ethanol. 
(b) Live 3T3 cells (green) are visible attached to fibrous sheets of electrospun PGS-PVA. Scale: 100 µm.  (c) SEM 
of 3T3 cells on PGS-PVA fibers. Note: all 3 groups have same cell density; 120-24oC fiber compaction is artifact of 
HMDS dehydration that was not observed if lyophilized samples.  Scale: 100 µm 
 
Advantages of OGS-PVA electrospinning 
Electrospun OGS-PVA offers advantages to both traditional SCPL PGS fabrication and 
other PGS electrospinning approaches.  This work was motivated by the need for stronger PGS 
scaffolds.  Tubular constructs fabricated by electrospinning OGS-PVA around small mandrels 
produce mechanically-robust scaffolds that permit easy suturing, stretching, and bending (Figure 
38A).  Additionally, SCPL is a labor-intensive method that requires a mold to hold the 
prepolymer in place until crosslinked and can be difficult to reproduce.  SEM of electrospun 
scaffolds reveal a near-homogenous fibrous cross-section and uniform wall thickness (Figure 
38B&C).      
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Figure 38. PGS-PVA fibrous conduits(a) 1.4 mm diameter tubular conduits demonstrate elastic properties 
and kink resistance during bending.  (b) The fibrous morphology of these conduits can be observed in the cross-
section (Scale: 200 µm, Insert: 20 µm).  (c) The lumen and albumen are fibrous with some fusion of fibers on the 
luminal side, which was initially in contact with the mandrel used during fabrication. (Scale: 10 µm) 
 
The cohesive property of OGS and the slight fiber fusion that occurs during thermal 
crosslinking make it useful for constructing multi-laminate constructs.  This is achieved by 
stacking OGS-PVA sheets (Figure 39A) between Teflon blocks during thermal crosslinking.  
This offers a route to produce thick fibrous constructs (Figure 39B) that would otherwise take 
very long to electrospin.  Furthermore, this bonding method presents a modular approach 
whereby different components can be fixed together by crosslinking.  One example of this is 
shown in Figure 39 C&D where fibrous tubular PGS-PVA grafts are inserted into a PGS-PVA 
microvascular scaffold to provide a site for anastamosis with host vasculature.   
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Figure 39. Multi-laminate PGS constructs.  (a) Fibrous OGS-PVA sheets are stacked and placed between 
Teflon blocks to prevent curling during thermal crosslinking.  (b) SEM of multi-laminate PGS construct (~2mm 
thick- y axis) and fibrous (insert).  (c) Fabrication of PGS AV-shunt grafts by insertion of tubular OGS-PVA within 
microvascular scaffolds before thermal crosslinking.  (d) PGS AV-shunt grafts after crosslinking and washing. 
 
Furthermore, our method offers several key advantages to existing electrospinning 
approaches: 1) The elasticity and kPa modulus of thermally crosslinked PGS are retained. These 
mechanical properties are unique features of PGS that are believed to be critical in providing 
cells the mechanical stimuli to promote elastin formation.  This elastic behavior requires the 
cross-linking of OGS to PGS as well as the removal of other polymers that alter mechanical 
response.  2) Potentially toxic components are minimized. Crosslinking achieved with heat 
minimizes residual toxicity compared with other methods.  Noncrosslinked OGS and free 
monomers which may be harmful are removed via washes in ethanol, a benign solvent.  The 
PVA removal in water is also nontoxic. 3) The technique is inexpensive. Disposable needles 
($0.35) cost much less than custom coaxial needles ($790) used for core-shell electrospinning.   
Additionally, use of standard OGS avoids costly modifications (e.g. OGS-acrylate) which are 
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often costly to scale up.  The PVA used as the carrier polymer for this experiment cost just 
$18/kg compared to $164/kg for gelatin (Sigma), $344/kg for PCL (Sigma), and $15,000/kg for 
PLLA (Sigma).  This method also saves significant time since the electrospinning is stable and 
can be left alone with minimal oversight.    
5.1.4 Summary 
We demonstrate a simple method for electrospinning PGS using standard electrospinning 
techniques.  This approach offers advantages to other fabrication methods, such as SCPL, by 
producing mechanically strong and fibrous scaffolds.  Additionally, it reduces cost and safety 
concerns associated with other electrospinning approaches.  This technique provides a new tool 
for processing several types of PGS scaffolds with more reliable handling for eventual 
implantation.    
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6.0  FINAL SUMMARY 
While many common methods for producing TE scaffolds have actually been borrowed 
from other disciplines such as textiles (electrospinning), integrated circuits (micropatterning), 
and prototyping (SFF), the work presented here describes the development of a new TE-specific 
fabrication technique that focuses on creating the complex structure of native ECM.  This 
method combines electrospinning and fused deposition modeling, which are both inexpensive 
technologies that are available to most labs.  We anticipate that future improvements of 
templated electrospinning will benefit from the rapid advancements in both of these active areas 
of research. 
6.1 BIOMIMETIC NERVE GUIDE-IMPACT AND FUTURE WORK 
To the best of our knowledge, this is the first multi-channel nerve guide composed 
entirely of electrospun fibers.  Our method offers spatial control of the microchannels that is not 
offered by many other approaches.  Additionally, we efficiently present a high number of aligned 
fibers at low density to provide topographical guidance for axons and Schwann cells.  Repair of 
peripheral nerve injuries using existing conduits has shown moderate success for short defects 
(<3cm).  However, current literature and opinions suggest that topographical features such as 
these are essential to repair of larger nerve gaps.168  Thus, we anticipate that our nerve guide may 
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create a norm for repair of large nerve gaps.  To yield optimal outcomes, these guides will likely 
need to be combined with the appropriate cells and stimulatory molecules.    
Preliminary tests with the PCL and PCL/PLGA nerve guides highlight the importance of 
material selection for peripheral nerve repair.  The slow degradation and thick channel walls 
significantly limited the area for regeneration to occur.  This was addressed in subsequent 
iterations by using much thinner walls and faster-degrading PLGA.  However, the inflammatory 
response from this material resulted in fibrotic tissue formation that impaired regeneration.  
These results motivated the development of electrospun PGS which should rapidly degrade and 
match the mechanical properties of native nerve.  We anticipate that PGS guides in combination 
with ECM proteins and growth factors can shift the response toward constructive remodeling. 
Yet, a concern for PGS nerve guides is that if these are used to repair large defects, the rapid 
degradation may cause collapse of the guide before it can be replaced with new ECM.  Thus, a 
material gradient may be necessary to match the degradation rate with the remodeling process.  
Finally, we can foresee using similar multi-channel designs to develop scaffolds for other tissues 
with similar longitudinal channels such as skeletal muscle and bone. 
6.2 MICROVASCULAR NETWORK 
We demonstrated successful endothelialization of a unique microvascular network that is 
fibrous and strong.  We believe that this approach makes our technique more applicable for in 
vivo scaffolds than other methods which are often weak and difficult to suture.  The small A-V 
loop presented in this work will be used to study in situ endothelialization and optimize 
parameters such as heparinization and hemodynamics.  Ultimately, these structures will be 
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incorporated into large organ scaffolds to provide rapid vascularization for parenchymal cells.  
Similarly, separate channels maybe used to spatially control seeding of parenchymal cells.   
Significant challenges must still be overcome before adoption of this method for 
vascularization.  One limitation is the difficulty connecting vessels between layers.  While 
pseudo-3D constructs can be produced by rolling or stacking, the stratified nature of this method 
makes it difficult to make true 3D networks.  A second challenge is creating microvessels over 
the full range of diameters, from millimeters to tens of microns.  First, the template production 
should be capable of matching sizes in this entire range.  Secondly, deposition of electrospun 
fibers has been shown to be affected by the height of insulators, resulting in “tent-like” fibers 
that do not tightly encapsulate the template.246  If the template spacing is too narrow, these fibers 
can form bridges spanning templates, resulting in loss of resolution.  A possible remedy to both 
of these challenges is to replace the random deposition of electrospun fibers with the precise 
positioning of fibers by direct-write melt electrospinning.  Both the FDM and melt-
electrospinning components could be attached to motorized stages for seamless and automated 
production.  Further, reverse thermal gels may replace thermoplastics as the template material to 
avoid melting the scaffold while permitting incorporation of encapsulated cells. 
6.3 FIBROUS POLY(GLYCEROL SEBACATE) 
We produced fibrous PGS without chemical modification or changes to the crosslinking 
regimen.  This should enable rapid and economical scale-up of electrospun PGS scaffolds.  The 
electrospinning process should also lead to more reliable manufacturing as compared to salt-
leaching methods.  The most significant achievement from this work is the improved mechanical 
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strength, notably the suture retention.  Scaffolds produced by salt-leaching tore easily, making 
them difficult to use in load-bearing applications without additional support material.  Thus, 
electrospun PGS should permit better adoption of PGS scaffolds by both researchers and 
surgeons.   
PGS offers several advantages over other available biomaterials.  For instance, few 
materials have low a modulus suitable for soft tissue repair.  The elastic property of PGS allows 
it to elongate with body movement, resulting in significant elastin synthesis in vivo.  
Additionally, the tendency of PGS prepolymer to flow and fuse has been previously considered a 
drawback of PGS.  However, we were able to use this effect as an advantage to produce multi-
laminate structures.  While additive manufacturing for tissue engineering is becoming a crowded 
area of research, no one to our knowledge is developing laminated object manufacturing (LOM) 
for biological applications.  We believe that the ability to easily produce sheets of fibrous PGS 
which can be laminated together to form larger constructs presents a promising opportunity for 
future exploration. 
Several challenges still exist pertaining to the development of electrospun PGS.  First, the 
electrospinning concentrations and ratios to obtain fibers fall within a narrow window.  Polymer 
solutions outside this range results in electrospraying, total fiber fusion, or fiber dissociation.  
Thus, tailoring fiber diameter, composition, and morphology is challenging.  Increasing porosity 
within electrospun scaffolds is another challenge that is familiar to most electrospinning 
techniques.  Future work will involve incorporating additional PVA domains that may be 
removed to yield higher porosity.  Finally, the rapid degradation of PGS may not be appropriate 
for some applications.  A collection of poly(polyol sebacate)s have been reported in the literature 
and combining these may provide the ability to meet degradation requirements.283  
 95 
6.4 FINAL CONCLUSIONS 
The body contains amazing complexity that may be taken for granted until we aim to 
repair it.  While creating entire organs de novo may be enticing, it can also be tempting to over-
engineer solutions.  Complex solutions are challenging to commercialize, ultimately failing to 
provide therapeutic benefit to patients.  The methods described in this dissertation present a 
simple and versatile technique capable of introducing micropatterns within electrospun scaffolds.  
This technique was first demonstrated in the context of peripheral nerve guides, resulting in 
scaffold architecture this was almost indistinguishable from that of native nerve.  Additionally, 
endothelialization of the microvascular network established proof-of-concept and laid the 
foundation to tackle the daunting challenge of vascularizing electrospun constructs.  Finally, 
electrospun PGS not only addressed material shortcomings relating to templated electrospinning, 
but also significantly improved strength of PGS scaffolds, impacting a wide range of 
applications.  We anticipate that these results will greatly impact their respective fields while this 
technology rapidly improves due to the popularity of both tissue engineering and 3D printing. 
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APPENDIX A 
SECTION 5.0 SUPPLEMENTARY FIGURES 
 
A1. Effect of heating rate and PGS-PVA ratio on fiber morphology.  Both the mandrel-contacting and outer 
surfaces of the fibrous sheets are shown (left/right). 
 
 97 
 
A2. Remaining mass of PGS films washed with water and ethanol.  (No error bars for 120-24h since 
samples stuck together and were grouped in measurement)  
 
 
A3. Mechanical Testing of Fibrous Sheets of Electrospun PGS-gelatin blends (71% PGS- 29% Gelatin 
Type B) crosslinked at 100oC or 150oC for 24h.  (a) Tensile testing of PGS-gelatin blends reveals large hydration-
dependent changes in mechanical behavior.  Hydrated samples are compared to electrospun gelatin (dry) and PGS 
films controls.  Dry PGS-gelatin profiles exhibit stress-strain curves similar to that of gelatin at low strain and PGS 
at higher strain.  Hydrated PGS-gelatin samples exhibit a low modulus similar to PGS and high strain to failure that 
exceeds PGS films.  (b) Suture retention of PGS-gelatin blends shows rapid propagation of the tear defect caused by 
the suture. 
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